Cover Page
Cover Page - USD ($) $ in Billions | 12 Months Ended | ||
Dec. 31, 2023 | Feb. 02, 2024 | Jun. 30, 2023 | |
Entity Information [Line Items] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Current Fiscal Year End Date | --12-31 | ||
Document Period End Date | Dec. 31, 2023 | ||
Document Transition Report | false | ||
Entity File Number | 001-38017 | ||
Entity Registrant Name | SNAP INC | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 45-5452795 | ||
Entity Address, Address Line One | 3000 31st Street | ||
Entity Address, City or Town | Santa Monica | ||
Entity Address, State or Province | CA | ||
Entity Address, Postal Zip Code | 90405 | ||
City Area Code | (310) | ||
Local Phone Number | 399-3339 | ||
Title of 12(b) Security | Class A Common Stock, par value $0.00001 per share | ||
Trading Symbol | SNAP | ||
Security Exchange Name | NYSE | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Document Financial Statement Error Correction | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 14.8 | ||
Amendment Flag | false | ||
Document Fiscal Year Focus | 2023 | ||
Document Fiscal Period Focus | FY | ||
Entity Central Index Key | 0001564408 | ||
Class A | |||
Entity Information [Line Items] | |||
Entity Common Stock Shares Outstanding | 1,396,476,171 | ||
Class B | |||
Entity Information [Line Items] | |||
Entity Common Stock Shares Outstanding | 22,528,406 | ||
Class C | |||
Entity Information [Line Items] | |||
Entity Common Stock Shares Outstanding | 231,626,943 |
Audit Information
Audit Information | 12 Months Ended |
Dec. 31, 2023 | |
Audit Information [Abstract] | |
Auditor Firm ID | 42 |
Auditor Name | Ernst & Young LLP |
Auditor Location | Los Angeles, CA, United States |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Cash flows from operating activities | |||
Net loss | $ (1,322,485) | $ (1,429,653) | $ (487,955) |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||
Depreciation and amortization | 168,441 | 202,173 | 119,141 |
Stock-based compensation | 1,324,004 | 1,387,787 | 1,092,135 |
Amortization of debt issuance costs | 7,361 | 6,865 | 4,311 |
Losses (gains) on debt and equity securities, net | 33,027 | 36,838 | (289,052) |
Induced conversion expense related to convertible notes | 0 | 0 | 41,538 |
Other | (26,958) | 15,596 | 8,643 |
Change in operating assets and liabilities, net of effect of acquisitions: | |||
Accounts receivable, net of allowance | (98,127) | (119,780) | (332,967) |
Prepaid expenses and other current assets | (9,920) | (40,917) | (26,607) |
Operating lease right-of-use assets | 70,674 | 71,441 | 47,258 |
Other assets | 2,238 | (504) | (10,916) |
Accounts payable | 94,988 | 46,492 | 53,579 |
Accrued expenses and other current liabilities | 62,130 | 71,706 | 117,092 |
Operating lease liabilities | (68,007) | (68,886) | (49,294) |
Other liabilities | 9,155 | 5,456 | 5,974 |
Net cash provided by (used in) operating activities | 246,521 | 184,614 | 292,880 |
Cash flows from investing activities | |||
Purchases of property and equipment | (211,727) | (129,306) | (69,875) |
Purchases of strategic investments | (7,770) | (26,346) | (41,160) |
Sales of strategic investments | 7,559 | 63,276 | 36,777 |
Cash paid for acquisitions, net of cash acquired | (50,254) | (67,067) | (310,915) |
Purchases of marketable securities | (2,048,273) | (3,485,638) | (2,438,983) |
Sales of marketable securities | 459,481 | 75,716 | 379,555 |
Maturities of marketable securities | 2,424,717 | 2,525,215 | 2,536,725 |
Other | (2,779) | (18,125) | (1,897) |
Net cash provided by (used in) investing activities | 570,954 | (1,062,275) | 90,227 |
Cash flows from financing activities | |||
Proceeds from issuance of convertible notes, net of issuance costs | 0 | 1,483,500 | 1,137,227 |
Purchase of capped calls | 0 | (177,000) | (86,825) |
Proceeds from the exercise of stock options | 1,038 | 4,272 | 14,671 |
Payments of debt issuance costs | 0 | (3,006) | 0 |
Repurchases of Class A non-voting common stock | (189,394) | (1,001,052) | 0 |
Deferred payments for acquisitions | (270,433) | 0 | 0 |
Net cash provided by (used in) financing activities | (458,789) | 306,714 | 1,065,073 |
Change in cash, cash equivalents, and restricted cash | 358,686 | (570,947) | 1,448,180 |
Cash, cash equivalents, and restricted cash, beginning of period | 1,423,776 | 1,994,723 | 546,543 |
Cash, cash equivalents, and restricted cash, end of period | 1,782,462 | 1,423,776 | 1,994,723 |
Supplemental disclosures | |||
Cash paid for income taxes, net | 30,924 | 12,087 | 25,333 |
Cash paid for interest | $ 10,244 | $ 8,873 | $ 10,887 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement [Abstract] | |||
Revenue | $ 4,606,115 | $ 4,601,847 | $ 4,117,048 |
Costs and expenses: | |||
Cost of revenue | 2,114,117 | 1,815,342 | 1,750,246 |
Research and development | 1,910,862 | 2,109,800 | 1,565,467 |
Sales and marketing | 1,122,092 | 1,118,746 | 792,764 |
General and administrative | 857,423 | 953,265 | 710,640 |
Total costs and expenses | 6,004,494 | 5,997,153 | 4,819,117 |
Operating loss | (1,398,379) | (1,395,306) | (702,069) |
Interest income | 168,394 | 58,597 | 5,199 |
Interest expense | (22,024) | (21,459) | (17,676) |
Other income (expense), net | (42,414) | (42,529) | 240,175 |
Loss before income taxes | (1,294,423) | (1,400,697) | (474,371) |
Income tax benefit (expense) | (28,062) | (28,956) | (13,584) |
Net loss | $ (1,322,485) | $ (1,429,653) | $ (487,955) |
Net loss per share attributable to Class A, Class B, and Class C common stockholders (Note 3): | |||
Basic (in usd per share) | $ (0.82) | $ (0.89) | $ (0.31) |
Diluted (in usd per share) | $ (0.82) | $ (0.89) | $ (0.31) |
Weighted average shares used in computation of net loss per share: | |||
Basic (in shares) | 1,612,504 | 1,608,304 | 1,558,997 |
Diluted (in shares) | 1,612,504 | 1,608,304 | 1,558,997 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Statement of Comprehensive Income [Abstract] | |||
Net loss | $ (1,322,485) | $ (1,429,653) | $ (487,955) |
Other comprehensive income (loss), net of tax | |||
Unrealized gain (loss) on marketable securities, net of tax | 8,269 | (9,307) | (1,735) |
Foreign currency translation | 12,836 | (10,188) | (14,107) |
Total other comprehensive income (loss), net of tax | 21,105 | (19,495) | (15,842) |
Total comprehensive loss | $ (1,301,380) | $ (1,449,148) | $ (503,797) |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Current assets | ||
Cash and cash equivalents | $ 1,780,400 | $ 1,423,121 |
Marketable securities | 1,763,680 | 2,516,003 |
Accounts receivable, net of allowance | 1,278,176 | 1,183,092 |
Prepaid expenses and other current assets | 153,587 | 134,431 |
Total current assets | 4,975,843 | 5,256,647 |
Property and equipment, net | 410,326 | 271,777 |
Operating lease right-of-use assets | 516,862 | 370,952 |
Intangible assets, net | 146,303 | 204,480 |
Goodwill | 1,691,827 | 1,646,120 |
Other assets | 226,597 | 279,562 |
Total assets | 7,967,758 | 8,029,538 |
Current liabilities | ||
Accounts payable | 278,961 | 181,774 |
Operating lease liabilities | 49,321 | 46,485 |
Accrued expenses and other current liabilities | 805,836 | 987,340 |
Total current liabilities | 1,134,118 | 1,215,599 |
Convertible senior notes, net | 3,749,400 | 3,742,520 |
Operating lease liabilities, noncurrent | 546,279 | 386,271 |
Other liabilities | 123,849 | 104,450 |
Total liabilities | 5,553,646 | 5,448,840 |
Commitments and contingencies (Note 8) | ||
Stockholders’ equity | ||
Treasury stock, at cost. 49,200 and 51,312 shares of Class A non-voting common stock at December 31, 2023 and December 31, 2022, respectively. | (479,903) | (500,514) |
Additional paid-in capital | 14,613,404 | 13,309,828 |
Accumulated deficit | (11,726,536) | (10,214,657) |
Accumulated other comprehensive income (loss) | 7,131 | (13,974) |
Total stockholders’ equity | 2,414,112 | 2,580,698 |
Total liabilities and stockholders’ equity | 7,967,758 | 8,029,538 |
Class A Non-voting Common Stock | ||
Stockholders’ equity | ||
Common stock, value | 14 | 13 |
Class B Voting Common Stock | ||
Stockholders’ equity | ||
Common stock, value | 0 | 0 |
Class C Voting Common Stock | ||
Stockholders’ equity | ||
Common stock, value | $ 2 | $ 2 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares | Dec. 31, 2023 | Dec. 31, 2022 | Sep. 30, 2022 | Dec. 31, 2021 |
Common stock, outstanding (in shares) | 1,694,696,000 | 1,625,398,000 | 1,619,283,000 | |
Class A Non-voting Common Stock | ||||
Common stock, par value (in usd per share) | $ 0.00001 | $ 0.00001 | ||
Common stock, authorized (in shares) | 3,000,000,000 | 3,000,000,000 | ||
Common stock, issued (in shares) | 1,440,540,591 | 1,371,242,000 | ||
Common stock, outstanding (in shares) | 1,391,341,262 | 1,319,930,000 | ||
Treasury stock, common (in shares) | 49,200,000 | 51,312,000 | 51,300,000 | |
Class B Voting Common Stock | ||||
Common stock, par value (in usd per share) | $ 0.00001 | $ 0.00001 | ||
Common stock, authorized (in shares) | 700,000,000 | 700,000,000 | ||
Common stock, issued (in shares) | 22,528,406 | 22,529,000 | ||
Common stock, outstanding (in shares) | 22,528,406 | 22,529,000 | ||
Class C Voting Common Stock | ||||
Common stock, par value (in usd per share) | $ 0.00001 | $ 0.00001 | ||
Common stock, authorized (in shares) | 260,887,848 | 260,888,000 | ||
Common stock, issued (in shares) | 231,626,943 | 231,627,000 | ||
Common stock, outstanding (in shares) | 231,626,943 | 231,627,000 |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands | Total | Treasury stock | Additional paid-in capital | Additional paid-in capital Cumulative Effect, Period of Adoption, Adjustment | Accumulated deficit | Accumulated deficit Cumulative Effect, Period of Adoption, Adjustment | Accumulated other comprehensive income (loss) | Class A | Class A Common stock | Class A Common stock Class A Non-Voting Common Stock Conversion From Class B Voting Common Stock | Class B | Class B Common stock | Class B Common stock Class A Non-Voting Common Stock Conversion From Class B Voting Common Stock | Class C | Class C Common stock |
Common stock, beginning of period (in shares) at Dec. 31, 2020 | 0 | 0 | 0 | 1,248,010,000 | 23,696,000 | 231,627,000 | |||||||||
Treasury stock, beginning of period (in shares) at Dec. 31, 2020 | 0 | ||||||||||||||
Balance, beginning of period at Dec. 31, 2020 | $ 0 | $ 10,200,141 | $ (664,021) | $ (7,891,542) | $ 95,031 | $ 21,363 | $ 12 | $ 0 | $ 2 | ||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||
Shares issued in connection with exercise of stock options under stock-based compensation plans (in shares) | 1,174,000 | 168,000 | |||||||||||||
Issuance of Class A non-voting common stock in connection with acquisitions (in shares) | 6,732,000 | ||||||||||||||
Issuance of Class A non-voting common stock for vesting of restricted stock units and restricted stock awards, net (in shares) | 55,466,000 | ||||||||||||||
Issuance of Class A non-voting common stock for vesting of restricted stock units and restricted stock awards, net | $ 1 | ||||||||||||||
Issuance of Class A non-voting common stock for the induced conversion related to convertible senior notes (in shares) | 52,410,000 | ||||||||||||||
Issuance of Class A non-voting common stock for the induced conversion related to convertible senior notes | 1,175,191 | $ 1 | |||||||||||||
Conversion of common stock to common stock (in shares) | 1,095,000 | (1,095,000) | |||||||||||||
Stock-based compensation expense | 1,088,506 | ||||||||||||||
Shares issued in connection with exercise of stock options under stock-based compensation plans | 14,680 | ||||||||||||||
Issuance of Class A non-voting common stock in connection with acquisitions and divestitures | 341,425 | ||||||||||||||
Purchase of capped calls | $ (86,825) | ||||||||||||||
Net loss | $ (487,955) | $ (487,955) | $ (408,118) | $ (7,339) | $ (72,498) | ||||||||||
Other comprehensive income (loss), net of tax | $ (15,842) | $ (15,842) | |||||||||||||
Common stock, end of period (in shares) at Dec. 31, 2021 | 1,619,283,000 | 0 | 0 | 0 | 1,364,887,000 | 22,769,000 | 231,627,000 | ||||||||
Treasury stock, end of period (in shares) at Dec. 31, 2021 | 0 | ||||||||||||||
Balance, end of period at Dec. 31, 2021 | $ 3,790,168 | $ 0 | $ 12,069,097 | $ (8,284,466) | $ 5,521 | $ 14 | $ 0 | $ 2 | |||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||
Shares issued in connection with exercise of stock options under stock-based compensation plans (in shares) | 334,000 | 58,000 | |||||||||||||
Issuance of Class A non-voting common stock in connection with acquisitions (in shares) | 1,277,000 | ||||||||||||||
Issuance of Class A non-voting common stock for vesting of restricted stock units and restricted stock awards, net (in shares) | 58,342,000 | ||||||||||||||
Conversion of common stock to common stock (in shares) | 298,000 | (298,000) | |||||||||||||
Repurchases of Class A non-voting common stock (in shares) | (105,208,000) | ||||||||||||||
Repurchases of Class A non-voting common stock | $ (1) | ||||||||||||||
Repurchases of Class A non-voting common stock (in shares) | 105,208,000 | ||||||||||||||
Repurchases of Class A non-voting common stock | $ (1,001,052) | ||||||||||||||
Retirement of Class A non-voting common stock (in shares) | (53,896,000) | ||||||||||||||
Retirement of Class A non-voting common stock | $ 500,538 | (500,538) | |||||||||||||
Stock-based compensation expense | 1,369,407 | ||||||||||||||
Shares issued in connection with exercise of stock options under stock-based compensation plans | 4,285 | ||||||||||||||
Issuance of Class A non-voting common stock in connection with acquisitions and divestitures | 44,039 | ||||||||||||||
Purchase of capped calls | $ (177,000) | ||||||||||||||
Net loss | (1,429,653) | $ (1,429,653) | $ (1,203,614) | $ (20,141) | $ (205,898) | ||||||||||
Other comprehensive income (loss), net of tax | $ (19,495) | $ (19,495) | |||||||||||||
Common stock, end of period (in shares) at Dec. 31, 2022 | 1,625,398,000 | 0 | 0 | 0 | 1,319,930,000 | 1,319,930,000 | 22,529,000 | 22,529,000 | 231,627,000 | 231,627,000 | |||||
Treasury stock, end of period (in shares) at Dec. 31, 2022 | 51,312,000 | 51,312,000 | |||||||||||||
Balance, end of period at Dec. 31, 2022 | $ 2,580,698 | $ (500,514) | $ 13,309,828 | $ (10,214,657) | $ (13,974) | $ 13 | $ 0 | $ 2 | |||||||
Treasury stock, beginning of period (in shares) at Sep. 30, 2022 | 51,300,000 | ||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||
Retirement of Class A non-voting common stock (in shares) | (53,900,000) | ||||||||||||||
Retirement of Class A non-voting common stock | $ (500,500) | ||||||||||||||
Common stock, end of period (in shares) at Dec. 31, 2022 | 1,625,398,000 | 0 | 0 | 0 | 1,319,930,000 | 1,319,930,000 | 22,529,000 | 22,529,000 | 231,627,000 | 231,627,000 | |||||
Treasury stock, end of period (in shares) at Dec. 31, 2022 | 51,312,000 | 51,312,000 | |||||||||||||
Balance, end of period at Dec. 31, 2022 | $ 2,580,698 | $ (500,514) | $ 13,309,828 | $ (10,214,657) | $ (13,974) | $ 13 | $ 0 | $ 2 | |||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||
Shares issued in connection with exercise of stock options under stock-based compensation plans (in shares) | 599,000 | 565,000 | |||||||||||||
Issuance of Class A non-voting common stock for vesting of restricted stock units and restricted stock awards, net (in shares) | 86,557,000 | ||||||||||||||
Issuance of Class A non-voting common stock for vesting of restricted stock units and restricted stock awards, net | $ 1 | ||||||||||||||
Conversion of common stock to common stock (in shares) | 566,000 | (566,000) | |||||||||||||
Repurchases of Class A non-voting common stock (in shares) | (18,423,000) | ||||||||||||||
Repurchases of Class A non-voting common stock (in shares) | 18,423,000 | ||||||||||||||
Repurchases of Class A non-voting common stock | $ (189,394) | ||||||||||||||
Retirement of Class A non-voting common stock (in shares) | (18,423,000) | ||||||||||||||
Retirement of Class A non-voting common stock | $ 189,394 | (189,394) | |||||||||||||
Reissuances of Class A non-voting common stock for vesting of restricted stock units (in shares) | (2,112,000) | 2,112,000 | |||||||||||||
Reissuances of Class A non-voting common stock for vesting of restricted stock units | $ 20,611 | (20,611) | |||||||||||||
Stock-based compensation expense | 1,323,149 | ||||||||||||||
Shares issued in connection with exercise of stock options under stock-based compensation plans | $ 1,038 | ||||||||||||||
Net loss | (1,322,485) | $ (1,322,485) | $ (1,114,039) | $ (18,479) | $ (189,967) | ||||||||||
Other comprehensive income (loss), net of tax | $ 21,105 | $ 21,105 | |||||||||||||
Common stock, end of period (in shares) at Dec. 31, 2023 | 1,694,696,000 | 0 | 0 | 0 | 1,391,341,262 | 1,391,341,000 | 22,528,406 | 22,528,000 | 231,626,943 | 231,627,000 | |||||
Treasury stock, end of period (in shares) at Dec. 31, 2023 | 49,200,000 | 49,200,000 | |||||||||||||
Balance, end of period at Dec. 31, 2023 | $ 2,414,112 | $ (479,903) | $ 14,613,404 | $ (11,726,536) | $ 7,131 | $ 14 | $ 0 | $ 2 |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Snap Inc. is a technology company. Snap Inc. (“we,” “our,” or “us”), a Delaware corporation, is headquartered in Santa Monica, California. Our flagship product, Snapchat, is a visual messaging application that was created to help people communicate through short videos and images called “Snaps.” Basis of Presentation Our consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Our consolidated financial statements include the accounts of Snap Inc. and our wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Our fiscal year ends on December 31. Certain reclassifications have been made in the prior periods to conform to the current year's presentation. None of these reclassifications had a material impact on our consolidated financial statements. Use of Estimates The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements. Management’s estimates are based on historical information available as of the date of the consolidated financial statements and various other assumptions that we believe are reasonable under the circumstances. Actual results could differ from those estimates. Key estimates relate primarily to determining the fair value of assets and liabilities assumed in business combinations, evaluation of contingencies, uncertain tax positions, and the fair value of strategic investments. On an ongoing basis, management evaluates our estimates compared to historical experience and trends, which form the basis for making judgments about the carrying value of assets and liabilities. Concentrations of Business Risk We currently use both Google Cloud and Amazon Web Services for our hosting requirements. A disruption or loss of service from one or both of these partners could seriously harm our ability to operate. Although we believe there are other qualified providers that can provide these services, a transition to a new provider could create a significant disruption to our business and negatively impact our consolidated financial statements. Concentrations of Credit Risk Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash, cash equivalents, marketable securities, and accounts receivable. We maintain cash deposits, cash equivalent balances, and marketable securities with several financial institutions. Cash and cash equivalents may be withdrawn or redeemed on demand. We believe that the financial institutions that hold our cash and cash equivalents are financially sound and, accordingly, minimal credit risk exists with respect to these balances. We also maintain investments in U.S. government debt and agency securities, publicly traded equity securities, corporate debt securities, certificates of deposit, and commercial paper that carry high credit ratings and accordingly, minimal credit risk exists with respect to these balances. We extend credit to our customers based on an evaluation of their ability to pay amounts due under contractual arrangement and generally do not obtain or require collateral. Revenue Recognition Revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to receive in exchange for those goods or services. See Note 2 for additional information. Cost of Revenue Cost of revenue In addition, cost of revenue consists of payments to third-party infrastructure partners for hosting our products, which include expenses related to storage, computing, and bandwidth costs. Cost of revenue also includes third-party selling costs, personnel-related costs, facilities and other supporting overhead costs, including depreciation and amortization, and inventory costs. Advertising Advertising costs are expensed as incurred and were $24.9 million, $42.7 million, and $62.4 million for the years ended December 31, 2023, 2022, and 2021, respectively. Capital Structure We have three classes of authorized common stock – Class A common stock, Class B common stock, and Class C common stock. Class A common stockholders have no voting rights, Class B common stockholders are entitled to one vote per share, and Class C common stockholders are entitled to ten votes per share. Shares of our Class B common stock are convertible into an equivalent number of shares of our Class A common stock and generally convert into shares of our Class A common stock upon transfer. Shares of our Class C common stock are convertible into an equivalent number of shares of our Class B common stock and generally convert into shares of our Class B common stock upon transfer. Future Stock Split to be Effected in the Form of a Stock Dividend In July 2022, our board of directors determined that it was advisable and in our best interest to approve a stock split to be effected in the form of a special dividend of one share of Class A common stock on each outstanding share of our common stock at a future date (the “Future Stock Split”). In connection with the Future Stock Split, we entered into certain agreements (the “Co-Founder Agreements”) with Evan Spiegel and Robert Murphy, our co-founders, and certain of their respective affiliates requiring them, among other things, to convert shares of Class B common stock and Class C common stock into Class A common stock under certain circumstances. The Future Stock Split will not be declared and paid until the first business day following the date on which the average of the volume weighted average price (the “VWAP”) per share of Class A common stock equals or exceeds $40 per share for 65 consecutive trading days. If this does not occur by July 21, 2032, the Future Stock Split will not be declared and paid, and the Co-Founder Agreements will terminate. In June 2023, in connection with a proposed settlement of a class-action lawsuit, and as amended in December 2023, we agreed to modify the conditions for the Future Stock Split, subject to various conditions, including judicial approval of the settlement. If approved, the Future Stock Split will not be declared and paid until the first business day following the date on which (i) the VWAP per share of Class A common stock equals or exceeds $40 per share for 90 consecutive trading days (the “90-Day VWAP”) and (ii) the ratio of the 90-Day VWAP to $8.70 equals or exceeds the ratio of the average closing price of the S&P 500 Total Return index for the same 90 trading days for which the 90-Day VWAP was calculated to 8,862.85. The original ten year time period to trigger the Future Stock Split would remain unchanged. No adjustments have been made to share or per share amounts for Class A common stock in the accompanying consolidated financial statements for the effects of the Future Stock Split as these triggering conditions have not been met. Stock-based Compensation We measure and recognize compensation expense for stock-based payment awards, including stock options, restricted stock units (“RSUs”), and restricted stock awards (“RSAs”) granted to employees, directors, and advisors, based on the grant date fair value of the awards. The grant date fair value of stock options is estimated using a Black-Scholes option pricing model. The fair value of stock-based compensation for stock options is recognized on a straight-line basis, net of estimated forfeitures, over the period during which services are provided in exchange for the award. The grant date fair value of RSUs and RSAs is estimated based on the fair value of our underlying common stock. RSUs and RSAs vest on the satisfaction of a service-based condition. The service condition for RSUs and RSAs is generally satisfied in equal monthly or quarterly installments over three eriod. Stock-based compensation expense recognized for all periods presented is based on awards that are expected to vest, including an estimate of forfeitures. We estimate the forfeiture rate using historical forfeitures of equity awards and other expected changes in facts and circumstances, if any. A modification of the terms of a stock-based award is treated as an exchange of the original award for a new award with total compensation cost equal to the grant-date fair value of the original award plus the incremental value of the modification to the award. The future tax benefits on settlement of the above RSUs and RSAs is not expected to be material as currently we have established valuation allowances to reduce our net deferred tax assets to the amount that is more likely than not to be realized. The majority of the future tax benefits that arise on settlement of the above RSUs are in jurisdictions for which our net deferred tax assets have a full valuation allowance. Income Taxes We are subject to income taxes in the United States and numerous foreign jurisdictions. Deferred tax assets and liabilities are determined based on differences between the financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the deferred tax asset or liability is expected to be realized or settled. In evaluating our ability to recover deferred tax assets, we consider all available positive and negative evidence, including historical operating results, ongoing tax planning, and forecasts of future taxable income on a jurisdiction-by-jurisdiction basis. Based on the level of historical losses, we have established a valuation allowance to reduce our net deferred tax assets to the amount that is more likely than not to be realized. We recognize a tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in our consolidated financial statements from such positions are measured based on the largest benefit that has a greater than 50% likelihood of being realized. We recognize interest and penalties associated with tax matters as part of the income tax provision and include accrued interest and penalties with the related income tax liability on our consolidated balance sheets. Currency Translation and Remeasurement The functional currency of the majority of our foreign subsidiaries is the U.S. dollar. Monetary assets and liabilities denominated in a foreign currency are remeasured into U.S. dollars at the exchange rate on the balance sheet date. Revenue and expenses are remeasured at the average exchange rates during the period. Equity transactions and other non-monetary assets are remeasured using historical exchange rates. Foreign currency transaction gains and losses are recorded in other income (expense), net on our consolidated statement of operations. For those foreign subsidiaries where the local currency is the functional currency, adjustments to translate those statements into U.S. dollars are recorded in accumulated other comprehensive income (loss) in stockholders’ equity. Cash and Cash Equivalents Cash and cash equivalents consist of highly liquid investments with original maturities of 90 days or less from the date of purchase. Restricted Cash We are required to maintain restricted cash deposits to back letters of credit for certain property leases. These funds are restricted and have been classified in other assets on our consolidated balance sheets due to the nature of restriction. At December 31, 2023 and 2022, restricted cash balances were immaterial. Marketable Securities We hold investments in marketable securities consisting of U.S. government securities, U.S. government agency securities, publicly traded equity securities, corporate debt securities, certificates of deposit, and commercial paper. We classify marketable investments in debt securities as available-for-sale investments in our current assets because they represent investments available for current operations. Our available-for-sale investments in debt securities are carried at fair value with any unrealized gains and losses, included in accumulated other comprehensive (loss) income in stockholders’ equity. Available-for-sale debt securities with an amortized cost basis in excess of estimated fair value are assessed to determine what amount of that difference, if any, is caused by expected credit losses, with any allowance for credit losses recognized as a charge in other income (expense), net on our consolidated statements of income. We did not record any credit losses on our available-for-sale debt securities in any of the periods presented. We determine gains or losses on the sale or maturities of marketable securities using the specific identification method and these gains or losses are recorded in other income (expense), net in our consolidated statements of operations. Publicly traded equity securities are carried at fair value with any unrealized gains and losses recorded in other income (expense), net in our consolidated statements of operations. Strategic Investments We hold strategic investments primarily in privately held companies, consisting primarily of equity securities without readily determinable fair values, and to a lesser extent, debt securities. We adjust the carrying value of these equity securities to fair value upon observable transactions for identical or similar investments of the same issuer or upon impairment. All strategic investments are reviewed periodically for impairment. Any adjustments to carrying value of these investments are recorded in other income (expense), net in our consolidated statements of operations. Strategic investments are included within other assets in our consolidated balance sheets. When we exercise significant influence over, but do not control the investee, such strategic investments are accounted for using the equity method. Under the equity method of accounting, we record our share of the results of the investments within other income (expense), net in our consolidated statements of operations. Fair Value Measurements Certain financial instruments are required to be recorded at fair value. Other financial instruments, including cash and cash equivalents and restricted cash, are recorded at cost, which approximates fair value. Additionally, accounts receivable, accounts payable, and accrued expenses approximate fair value because of the short-term nature of these financial instruments. Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are recorded at the invoiced amount less any allowance for doubtful accounts to reserve for potentially uncollectible receivables. To determine the amount of the allowance, we make judgments about the creditworthiness of customers based on ongoing credit evaluation and historical experience. At December 31, 2023 and 2022, the allowance for doubtful accounts was immaterial. Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. We compute depreciation using the straight-line method over the estimated useful lives of the assets, which is generally three years for computer hardware, software, and equipment, five years for furniture, and over the shorter of lease term or useful life of the assets for leasehold improvements. Buildings are generally depreciated over a useful life ranging from 20 to 45 years. Maintenance and repairs are expensed as incurred. Leases We have non-cancelable lease agreements for primarily offices that are recorded as operating lease right-of-use assets and operating lease liabilities in our consolidated balance sheets. We account for lease and non-lease components as a single lease component and do not record leases with an initial term of twelve months or less in our consolidated balance sheets. We use our incremental borrowing rate based on the information available at the lease commencement date to determine the present value of lease payments over the lease term . Our lease terms may include options to extend or terminate the lease when it is reasonably certain we will exercise that option. Certain agreements have free rent periods or escalating rent payment provisions. Rent expense is recognized on a straight-line basis over the lease term. Software Development Costs Software development costs include costs to develop software to be used to meet internal needs and applications used to deliver our services. We capitalize development costs related to these software applications once the preliminary project stage is complete and it is probable that the project will be completed and the software will be used to perform the function intended. Costs capitalized for developing such software applications were not material for the periods presented. Segments Our CEO is our chief operating decision maker ( “ CODM ” ). We have determined that we have a single operating segment. Our CEO evaluates performance and makes operating decisions about allocating resources based on financial data presented on a consolidated basis accompanied by disaggregated information about revenue by geographic region. Business Combinations We include the results of operations of the businesses that we acquire from the date of acquisition. We determine the fair value of the assets acquired and liabilities assumed based on their estimated fair values as of the respective date of acquisition. The excess purchase price over the fair values of identifiable assets and liabilities is recorded as goodwill. Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates including the selection of valuation methodologies, estimates of future revenue and cash flows, discount rates, and selection of comparable companies. Our estimates of fair value are based on assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, not to exceed one year from the date of acquisition, we may record adjustments to the assets acquired and liabilities assumed, with a corresponding offset to goodwill. At the conclusion of the measurement period, any subsequent adjustments are reflected in our consolidated statements of operations. When we issue payments or grants of equity to selling stockholders in connection with an acquisition, we evaluate whether the payments or awards are compensatory. This evaluation includes whether cash payments or stock award vesting is contingent on the continued employment of the selling stockholder beyond the acquisition date. If continued employment is required for the cash to be paid or stock awards to vest, the award is treated as compensation for post-acquisition services and is recognized as compensation expense. Transaction costs associated with business combinations are expensed as incurred, and are included in general and administrative expenses in our consolidated statements of operations. Goodwill Goodwill represents the excess of the purchase price over the fair value of net assets acquired in a business combination. We test goodwill for impairment at least annually, in the fourth quarter, or whenever events or changes in circumstances indicate that goodwill might be impaired. For all periods presented, we had a single operating segment and reporting unit structure. There were no impairment charges in any of the periods presented. Intangible Assets Intangible assets are carried at cost and amortized on a straight-line basis over their estimated useful lives. We determine the appropriate useful life of our intangible assets by measuring the expected cash flows of acquired assets. The estimated useful lives of intangible assets are generally as follows: Intangible Asset Estimated Useful Domain names 5 Years Trademarks 3 Years Acquired developed technology 3 to 7 Years Customer relationships 2 to 8 Years Patents 4 to 14 Years Impairment of Long-Lived Assets We evaluate recoverability of our property and equipment and intangible assets, excluding goodwill, when events or changes indicate the carrying amount of an asset may not be recoverable. Events and changes in circumstances considered in determining whether the carrying value of long-lived assets may not be recoverable include: significant changes in performance relative to expected operating results; significant changes in asset use; and significant negative industry or economic trends and changes in our business strategy. Recoverability of these assets is measured by comparison of their carrying amount to future undiscounted cash flows to be generated. If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. Legal Contingencies For legal contingencies, we accrue a liability for an estimated loss if the potential loss from any claim or legal proceeding is considered probable, and the amount can be reasonably estimated. Legal fees and expenses are expensed as incurred. Note 8 provides additional information regarding our legal contingencies. Recent Accounting Pronouncements In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities to provide greater disaggregation within their annual rate reconciliation, including new requirements to present reconciling items on a gross basis in specified categories, disclose both percentages and dollar amounts, and disaggregate individual reconciling items by jurisdiction and nature when the effect of the items meet a quantitative threshold. The guidance also requires disaggregating the annual disclosure of income taxes paid, net of refunds received, by federal (national), state, and foreign taxes, with separate presentation of individual jurisdictions that meet a quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024 on a prospective basis, with a retrospective option, and early adoption is permitted. We are currently evaluating the impact of adoption of this standard on our consolidated financial statements and disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities with a single reportable segment to provide all the disclosures required by this standard and all existing segment disclosures in Topic 280 on an interim and annual basis, including new requirements to disclose significant segment expenses that are regularly provided to the CODM and included within the reported measure(s) of a segment's profit or loss, the amount and composition of any other segment items, the title and position of the CODM, and how the CODM uses the reported measure(s) of a segment's profit or loss to assess performance and decide how to allocate resources. The guidance is effective for annual periods beginning after December 15, 2023, and interim periods beginning after December 15, 2024, applied retrospectively with early adoption permitted. We are currently evaluating the impact of adoption of this standard on our consolidated financial statements and disclosures. |
Revenue
Revenue | 12 Months Ended |
Dec. 31, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | Revenue We determine revenue recognition by first identifying the contract or contracts with a customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations in the contract, and recognizing revenue when, or as, we satisfy a performance obligation. Revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to receive in exchange for those goods or services. We determine collectability by performing ongoing credit evaluations and monitoring customer accounts receivable balances. Sales tax, including value added tax, is excluded from reported revenue. We generate substantially all of our revenues by offering various advertising products on Snapchat, which include Snap Ads and AR Ads, referred to as advertising revenue. AR Ads include Sponsored Lenses, which allow users to interact with an advertiser’s brand by enabling branded augmented reality experiences. The substantial majority of advertising revenue is generated from the display of advertisements on Snapchat through contractual agreements that are either based on the number of advertising impressions delivered or on a fixed fee basis over a period of time. Revenue related to agreements based on the number of impressions delivered is recognized when the advertisement is served. Revenue related to fixed fee arrangements is recognized ratably over the service period, typically less than 30 days in duration, and such arrangements do not contain minimum impression guarantees. In arrangements where another party is involved in providing specified services to a customer, we evaluate whether we are the principal or agent. In this evaluation, we consider if we obtain control of the specified goods or services before they are transferred to the customer, as well as other indicators such as the party primarily responsible for fulfillment, inventory risk, and discretion in establishing price. For advertising revenue arrangements where we are not the principal, we recognize revenue on a net basis. For the periods presented, revenue for arrangements where we are the agent was not material. We also generate revenue from subscriptions and sales of hardware products. For the periods presented, all such revenue was not material. The following table represents our revenue disaggregated by geography based on the billing address of the customer: Year Ended December 31, 2023 2022 2021 (in thousands) North America (1) (2) $ 2,952,301 $ 3,205,554 $ 2,871,369 Europe (3) 772,078 712,764 660,473 Rest of world 881,736 683,529 585,206 Total revenue $ 4,606,115 $ 4,601,847 $ 4,117,048 (1) North America includes Mexico, the Caribbean, and Central America. (2) United States revenue was $2.9 billion, $3.1 billion, and $2.8 billion for the years ended December 31, 2023, 2022, and 2021, respectively. (3) Europe includes Russia and Turkey. Effective March 2022, we halted advertising sales to Russian and Belarusian entities. |
Net Loss per Share
Net Loss per Share | 12 Months Ended |
Dec. 31, 2023 | |
Earnings Per Share [Abstract] | |
Net Loss per Share | Net Loss per Share We compute net loss per share using the two-class method required for multiple classes of common stock. We have three classes of authorized common stock for which voting rights differ by class. Basic net loss per share is computed by dividing net loss attributable to each class of stockholders by the weighted-average number of shares of stock outstanding during the period, adjusted for RSAs for which the risk of forfeiture has not yet lapsed. For the calculation of diluted net loss per share, net loss per share attributable to common stockholders for basic net loss per share is adjusted by the effect of dilutive securities, including awards under our equity compensation plans. Diluted net loss per share attributable to common stockholders is computed by dividing the resulting net loss attributable to common stockholders by the weighted-average number of fully diluted common shares outstanding. We use the if-converted method for calculating any potential dilutive effect of the convertible senior notes due in 2025, 2026, 2027, and 2028 (collectively, the “Convertible Notes”) on diluted net loss per share. The Convertible Notes would have a dilutive impact on net income per share when the average market price of Class A common stock for a given period exceeds the respective conversion price of the Convertible Notes. For the periods presented, our potentially dilutive shares relating to stock options, RSUs, RSAs, and Convertible Notes were not included in the computation of diluted net loss per share as the effect of including these shares in the calculation would have been anti-dilutive. The numerators and denominators of the basic and diluted net loss per share computations for our common stock are calculated as follows for the years ended December 31, 2023, 2022, and 2021: Year Ended December 31, 2023 2022 2021 (in thousands, except per share data) Class A Class B Class C Class A Class B Class C Class A Class B Class C Numerator: Net loss $ (1,114,039) $ (18,479) $ (189,967) $ (1,203,614) $ (20,141) $ (205,898) $ (408,118) $ (7,339) $ (72,498) Net loss attributable to common stockholders $ (1,114,039) $ (18,479) $ (189,967) $ (1,203,614) $ (20,141) $ (205,898) $ (408,118) $ (7,339) $ (72,498) Denominator: Basic shares: Weighted-average common shares - Basic 1,358,345 22,532 231,627 1,354,019 22,658 231,627 1,303,921 23,449 231,627 Diluted shares: Weighted-average common shares - Diluted 1,358,345 22,532 231,627 1,354,019 22,658 231,627 1,303,921 23,449 231,627 Net loss per share attributable to common stockholders: Basic $ (0.82) $ (0.82) $ (0.82) $ (0.89) $ (0.89) $ (0.89) $ (0.31) $ (0.31) $ (0.31) Diluted $ (0.82) $ (0.82) $ (0.82) $ (0.89) $ (0.89) $ (0.89) $ (0.31) $ (0.31) $ (0.31) The following potentially dilutive shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented: Year Ended December 31, 2023 2022 2021 (in thousands) Stock options 1,697 3,159 4,304 Unvested RSUs and RSAs 157,130 132,392 86,180 Convertible Notes (if-converted) 89,379 89,379 62,755 |
Stockholders' Equity
Stockholders' Equity | 12 Months Ended |
Dec. 31, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Stockholders' Equity | Stockholders’ Equity Common Stock As of December 31, 2023, we are authorized to issue 3,000,000,000 shares of Class A non-voting common stock, 700,000,000 shares of Class B voting common stock, and 260,887,848 shares of Class C voting common stock, each with a par value of $0.00001 per share. Class A common stockholders have no voting rights, Class B common stockholders are entitled to one vote per share, and Class C common stockholders are entitled to ten votes per share. Shares of our Class B common stock are convertible into an equivalent number of shares of our Class A common stock and generally convert into shares of our Class A common stock upon transfer. Shares of our Class C common stock are convertible into an equivalent number of shares of our Class B common stock and generally convert into shares of our Class B common stock upon transfer. Any dividends paid to the holders of the Class A common stock, Class B common stock, and Class C common stock will be paid on a pro rata basis. For the year ended December 31, 2023, we did not declare any dividends. On a liquidation event, as defined in our certificate of incorporation, any distribution to common stockholders is made on a pro rata basis to the holders of the Class A common stock, Class B common stock, and Class C common stock. As of December 31, 2023, there were 1,440,540,591 shares issued and 1,391,341,262 shares outstanding of Class A common stock, and 22,528,406 shares and 231,626,943 shares issued and outstanding of Class B common stock and Class C common stock, respectively. Stock-based Compensation Plans We maintain three share-based employee compensation plans: the 2017 Equity Incentive Plan (“2017 Plan”), the 2014 Equity Incentive Plan (“2014 Plan”), and the 2012 Equity Incentive Plan (“2012 Plan,” and collectively with the 2017 Plan and the 2014 Plan, the “Stock Plans”). In January 2017, our board of directors adopted the 2017 Plan, and in February 2017 our stockholders approved the 2017 Plan, effective on March 1, 2017, which serves as the successor to the 2014 Plan and 2012 Plan and provides for the grant of incentive stock options to employees, including employees of any parent or subsidiary, and for the grant of nonstatutory stock options, stock appreciation rights, RSAs, RSUs, performance stock awards, performance cash awards, and other forms of stock awards to employees, directors, and consultants, including employees and consultants of our affiliates. We do not expect to grant any additional awards under the 2014 Plan or 2012 Plan as of the effective date of the 2017 Plan, other than awards for up to 2,500,000 shares of Class A common stock to our employees and consultants in France under the 2014 Plan. Outstanding awards under the 2014 Plan and 2012 Plan continue to be subject to the terms and conditions of the 2014 Plan and 2012 Plan, respectively. Shares available for grant under the 2014 Plan and 2012 Plan, which were reserved but not issued or subject to outstanding awards under the 2014 Plan or 2012 Plan, respectively, as of the effective date of the 2017 Plan, were added to the reserves of the 2017 Plan. We initially reserved 87,270,108 shares of our Class A common stock for future issuance under the 2017 Plan. An additional number of shares of Class A common stock will be added to the 2017 Plan equal to (i) 96,993,064 shares of Class A common stock reserved for future issuance pursuant to outstanding stock options and unvested RSUs under the 2014 Plan, (ii) 37,228,865 shares of Class A common stock issuable on conversion of Class B common stock underlying stock options and unvested RSUs outstanding under the 2012 Plan, (iii) 17,858,235 shares of Class A common stock that were reserved for issuance under the 2014 Plan as of the date the 2017 Plan became effective, (iv) 11,004,580 shares of Class A common stock issuable on conversion of Class B common stock that were reserved for issuance under the 2012 Plan as of the date the 2017 Plan became effective, and (v) a maximum of 86,737,997 shares of Class A common stock that will be added pursuant to the following sentence. With respect to each share that returns to the 2017 Plan pursuant to (i) and (ii) of the prior sentence that was associated with an award that was outstanding under the 2014 Plan and 2012 Plan as of October 31, 2016, an additional share of Class A common stock will be added to the share reserve of the 2017 Plan, up to a maximum of 86,737,997 shares . The number of shares reserved for issuance under the 2017 Plan will increase automatically on January 1st of each calendar year, beginning on January 1, 2018 through January 1, 2027, by the lesser of (i) 5.0% of the total number of shares of our capital stock outstanding on December 31st of the immediately preceding calendar year, and (ii) a number determined by our board of directors. The maximum term for stock options granted under the 2017 Plan may not exceed ten years from the date of grant. The 2017 Plan will terminate ten years from the date our board of directors approved the plan, unless it is terminated earlier by our board of directors. 2017 Employee Stock Purchase Plan In January 2017, our board of directors adopted the 2017 Employee Stock Purchase Plan (“2017 ESPP”). Our stockholders approved the 2017 ESPP in February 2017. The 2017 ESPP became effective in connection with the IPO. A total of 16,484,690 shares of Class A common stock were initially reserved for issuance under the 2017 ESPP. No shares of our Class A common stock have been issued or offered under the 2017 ESPP. The number of shares of our Class A common stock reserved for issuance will automatically increase on January 1st of each calendar year, beginning on January 1, 2018 through January 1, 2027, by the lesser of (i) 1.0% of the total number of shares of our common stock outstanding on the last day of the calendar month before the date of the automatic increase, and (ii) 15,000,000 shares; provided that before the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth in clauses (i) and (ii). Restricted Stock Units and Restricted Stock Awards The following table summarizes the RSU and RSA activity during the year ended December 31, 2023: Class A Weighted- (in thousands, except per share data) Unvested at December 31, 2022 132,392 $ 18.28 Granted 148,701 $ 10.41 Vested (91,641) $ 15.71 Forfeited (32,322) $ 15.90 Unvested at December 31, 2023 157,130 $ 12.82 The total fair value of RSUs and RSAs vested for the years ended December 31, 2023, 2022, and 2021 was $1.0 billion, $1.2 billion, and $3.6 billion, respectively. Total unrecognized compensation cost related to outstanding RSUs and RSAs was $1.7 billion as of December 31, 2023 and is expected to be recognized over a weighted-average period of 2.0 years. Stock Options The following table summarizes the stock option award activity under the Stock Plans during the year ended December 31, 2023: Class A Class B Weighted- Weighted- Aggregate Intrinsic Value (1) (in thousands, except per share data) Outstanding at December 31, 2022 2,589 570 $ 9.68 4.05 $ 9,669 Granted — — $ — Exercised (599) (565) $ 0.89 Forfeited (298) — $ 14.27 Outstanding at December 31, 2023 1,692 5 $ 14.90 4.41 $ 5,225 Exercisable at December 31, 2023 1,692 5 $ 14.90 4.41 $ 5,225 Vested and expected to vest at December 31, 2023 1,692 5 $ 14.90 4.41 $ 5,225 (1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock option awards and the closing market price of our Class A common stock as of December 31, 2023 and December 31, 2022, respectively. The weighted-average fair value of stock options granted during the year ended December 31, 2022 and 2021 was $8.41 and $36.17 per share. The expense is estimated based on the option’s fair value as calculated by the Black-Scholes option pricing model. Stock-based compensation expense for stock options was not material for the years ended December 31, 2023, 2022, and 2021. As of December 31, 2023, there was no unrecognized compensation cost related to stock options granted under the Stock Plans. The total grant date fair value of stock options that vested for the years ended December 31, 2023, 2022, and 2021 was $1.1 million, $3.2 million, and $7.7 million, respectively. The intrinsic value of stock options exercised for the years ended December 31, 2023, 2022, and 2021 was $12.3 million, $5.9 million, and $69.4 million, respectively. Stock-Based Compensation Expense Total stock-based compensation expense by function was as follows: Year Ended December 31, 2023 2022 2021 (in thousands) Cost of revenue $ 9,555 $ 12,288 $ 17,221 Research and development 893,026 970,746 740,130 Sales and marketing 255,688 203,092 164,241 General and administrative 165,735 201,661 170,543 Total $ 1,324,004 $ 1,387,787 $ 1,092,135 Stock Repurchases In October 2023, our board of directors authorized a stock repurchase program of up to $500.0 million of our Class A common stock. During the fourth quarter of 2023, we repurchased 18.4 million shares of our Class A common stock for an aggregate of $189.4 million, including costs associated with the repurchases. As of December 31, 2023, the remaining availability under the stock repurchase authorization was $310.8 million. In October 2022, our board of directors authorized a stock repurchase program of up to $500.0 million of our Class A common stock. The program was completed in the fourth quarter of 2022, during which we repurchased, and subsequently retired, 53.9 million shares of our Class A common stock for an aggregate of $500.5 million, representing the entire amount approved by our board of directors and including costs associated with the repurchases. In July 2022, our board of directors authorized a stock repurchase program of up to $500.0 million of our Class A common stock. The program was completed in the third quarter of 2022, during which we repurchased 51.3 million shares of our Class A common stock for an aggregate of $500.5 million, representing the entire amount approved by our board of directors and including costs associated with the repurchases. These shares are recorded as treasury stock on our consolidated balance sheets and remain available for re-issuance. |
Business Acquisitions
Business Acquisitions | 12 Months Ended |
Dec. 31, 2023 | |
Business Combination and Asset Acquisition [Abstract] | |
Business Acquisitions | Business Acquisitions 2023 Acquisitions In 2023, aggregate purchase consideration for business acquisitions was $73.1 million, which primarily consisted of $56.3 million in cash and $12.6 million recorded in other liabilities in our consolidated balance sheet. Of the aggregate purchase consideration, $42.8 million was allocated to goodwill and the remainder primarily to identifiable intangible assets. The acquired assets are expected to enhance our existing platform, technology, and workforce. The goodwill amount represents synergies related to our existing platform expected to be realized from the business acquisitions and assembled workforce. The associated goodwill and intangible assets are not deductible for tax purposes. 2022 Acquisitions In 2022, we completed acquisitions to enhance our existing platform, technology, and workforce. The aggregate purchase consideration was $120.5 million, which included $17.7 million in cash, $44.0 million in shares of our Class A common stock, and $58.8 million recorded in other liabilities on our consolidated balance sheet. Of the aggregate purchase consideration, $69.3 million was allocated to goodwill and the remainder primarily to identifiable intangible assets. The goodwill amount represents synergies related to our existing platform expected to be realized from the business acquisitions and assembled workforce. Of the acquired goodwill and intangible assets, $101.7 million is deductible for tax purposes. 2021 Acquisitions Wave Optics In May 2021, we acquired Wave Optics Limited (“Wave Optics”), a display technology company that supplies light engines and diffractive waveguides for augmented reality displays. The total consideration was $541.8 million, of which $510.4 million represented purchase consideration and primarily consisted of 4.7 million shares of our Class A common stock with a fair value of $252.0 million, cash of $13.7 million, and a $238.4 million payable due no later than May 2023 in either cash, shares of our Class A common stock, or a combination of cash and shares of our Class A common stock, at our election. The remaining $31.4 million of total consideration transferred represented compensation for future employment services. The allocation of the total purchase consideration for this acquisition was as follows: Total (in thousands) Trademarks $ 20,584 Technology 77,118 Customer relationships 32,708 Goodwill 370,236 Net deferred tax liability (3,313) Other assets acquired and liabilities assumed, net 13,111 Total $ 510,444 The goodwill amount represents synergies expected to be realized from the business combination and assembled workforce. The associated goodwill and intangible assets are not deductible for tax purposes. Fit Analytics In March 2021, we acquired Fit Analytics GmbH (“Fit Analytics”), a sizing technology company that powers solutions for retailers and brands, to grow our e-commerce and shopping offerings. The purchase consideration for Fit Analytics was $124.4 million, which primarily represented current and future cash consideration payments. The allocation of the total purchase consideration for this acquisition was as follows: Total (in thousands) Trademarks $ 800 Technology 17,000 Customer relationships 17,000 Goodwill 88,132 Net deferred tax liability (5,643) Other assets acquired and liabilities assumed, net 7,160 Total $ 124,449 The goodwill amount represents synergies expected to be realized from this business combination and assembled workforce. The associated goodwill and intangible assets are not deductible for tax purposes. Other 2021 Acquisitions For the year ended December 31, 2021, we completed other acquisitions to enhance our existing platform, technology, and workforce. The aggregate purchase consideration was $266.1 million, which included $139.5 million in cash, $93.7 million in shares of our Class A common stock, and $32.9 million recorded in other liabilities on our consolidated balance sheets. The aggregate allocation of purchase consideration was as follows: Total (in thousands) Technology $ 64,150 Customer relationships 4,000 Goodwill 203,482 Net deferred tax liability (11,871) Other assets acquired and liabilities assumed, net 6,325 Total $ 266,086 The goodwill amount represents synergies related to our existing platform expected to be realized from the business acquisitions and assembled workforces. Of the acquired goodwill and intangible assets, $8.2 million is deductible for tax purposes. Additional Information on 2023, 2022, and 2021 Acquisitions The operating results of the above acquisitions were included in the results of our operations from the acquisition date and were not material to our consolidated revenue or consolidated operating loss. In addition, unaudited pro forma results of operations assuming the above acquisitions had taken place at the beginning of each period are not provided because the historical operating results of the acquired entities were not material and pro forma results would not be materially different from reported results for the periods presented. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets | 12 Months Ended |
Dec. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Intangible Assets | Goodwill and Intangible Assets The changes in the carrying amount of goodwill for the years ended December 31, 2023 and 2022 were as follows: Goodwill (in thousands) Balance as of December 31, 2021 $ 1,588,452 Goodwill acquired 69,291 Foreign currency translation (11,623) Balance as of December 31, 2022 $ 1,646,120 Goodwill acquired 42,780 Foreign currency translation 2,927 Balance as of December 31, 2023 $ 1,691,827 Intangible assets consisted of the following: December 31, 2023 Weighted- Gross Accumulated Net (in thousands, except years) Domain names 3.0 $ 745 $ (546) $ 199 Technology 2.8 323,313 (197,608) 125,705 Patents 8.8 39,373 (19,099) 20,274 Other — 6,000 (5,875) 125 $ 369,431 $ (223,128) $ 146,303 December 31, 2022 Weighted- Gross Accumulated Net (in thousands, except years) Domain names 4.0 $ 954 $ (690) $ 264 Trademarks 1.2 800 (478) 322 Technology 3.1 340,375 (178,427) 161,948 Customer relationships 5.7 21,000 (6,641) 14,359 Patents 9.1 39,373 (14,912) 24,461 Other 1.0 6,000 (2,874) 3,126 $ 408,502 $ (204,022) $ 204,480 Amortization of intangible assets for the years ended December 31, 2023, 2022, and 2021 was $81.1 million, $132.3 million, and $63.2 million, respectively. In 2023, we recognized $19.9 million in charges related to the revision of the useful lives and disposal of certain acquired intangible assets. In 2022, we revised the useful lives of certain customer relationships, trademarks, domain names, and technology, which resulted in a $49.3 million increase to amortization expense for the year ended December 31, 2022. As of December 31, 2023, the estimated intangible asset amortization expense for the next five years and thereafter is as follows: Estimated (in thousands) Year ending December 31, 2024 $ 58,532 2025 42,513 2026 20,776 2027 12,104 2028 4,323 Thereafter 8,055 Total $ 146,303 |
Long-Term Debt
Long-Term Debt | 12 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Long-Term Debt | Long-Term Debt Convertible Notes 2028 Notes In February 2022, we entered into a purchase agreement for the sale of an aggregate of $1.50 billion principal amount of convertible senior notes due in 2028 (the “2028 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The net proceeds from the issuance of the 2028 Notes were $1.31 billion, net of debt issuance costs and cash used to purchase the capped call transactions (“2028 Capped Call Transactions”) discussed below. The debt issuance costs are amortized to interest expense using the effective interest rate method. The 2028 Notes are unsecured and unsubordinated obligations. Interest is payable in cash semi-annually in arrears beginning on September 1, 2022 at a rate of 0.125% per year. The 2028 Notes mature on March 1, 2028 unless repurchased, redeemed, or converted in accordance with their terms prior to such date. The 2028 Notes are convertible into cash, shares of our Class A common stock, or a combination of cash and shares of our Class A common stock, at our election, at an initial conversion rate of 17.7494 shares of Class A common stock per $1,000 principal amount of 2028 Notes, which is equivalent to an initial conversion price of approximately $56.34 per share of our Class A common stock. We may redeem for cash all or any portion of the 2028 Notes, at our option, on or after March 5, 2025 based on certain circumstances. 2027 Notes In April 2021, we entered into a purchase agreement for the sale of an aggregate of $1.15 billion principal amount of convertible senior notes due in 2027 (the “2027 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The net proceeds from the issuance of the 2027 Notes were $1.05 billion, net of debt issuance costs and cash used to purchase the capped call transactions (the “2027 Capped Call Transactions”) discussed below. The debt issuance costs are amortized to interest expense using the effective interest rate method. The 2027 Notes are unsecured and unsubordinated obligations which do not bear regular interest and for which the principal balance will not accrete. The 2027 Notes will mature on May 1, 2027 unless repurchased, redeemed, or converted in accordance with their terms prior to such date. The 2027 Notes are convertible into cash, shares of our Class A common stock, or a combination of cash and shares of our Class A common stock, at our election, at an initial conversion rate of 11.2042 shares of Class A common stock per $1,000 principal amount of 2027 Notes, which is equivalent to an initial conversion price of approximately $89.25 per share of our Class A common stock. We may redeem for cash all or portions of the 2027 Notes, at our option, on or after May 5, 2024 based on certain circumstances. 2025 Notes In April 2020, we entered into a purchase agreement for the sale of an aggregate of $1.0 billion principal amount of convertible senior notes due in 2025 (the “2025 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The net proceeds from the issuance of the 2025 Notes were $888.6 million, net of debt issuance costs and cash used to purchase the capped call transactions (the “2025 Capped Call Transactions”) discussed below. The debt issuance costs are amortized to interest expense using the effective interest rate method. The 2025 Notes are unsecured and unsubordinated obligations. Interest is payable in cash semi-annually in arrears beginning on November 1, 2020 at a rate of 0.25% per year. The 2025 Notes mature on May 1, 2025 unless repurchased, redeemed, or converted in accordance with their terms prior to such date. The 2025 Notes are convertible into cash, shares of our Class A common stock, or a combination of cash and shares of our Class A common stock, at our election, at an initial conversion rate of 46.1233 shares of Class A common stock per $1,000 principal amount of 2025 Notes, which is equivalent to an initial conversion price of approximately $21.68 per share of our Class A common stock. We may redeem for cash all or portions of the 2025 Notes, at our option, on or after May 6, 2023 based on certain circumstances. 2026 Notes In August 2019, we entered into a purchase agreement for the sale of an aggregate of $1.265 billion principal amount of convertible senior notes due in 2026 (the “2026 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The net proceeds from the issuance of the 2026 Notes were $1.15 billion, net of debt issuance costs and cash used to purchase the capped call transactions (the “2026 Capped Call Transactions”) discussed below. The debt issuance costs are amortized to interest expense using the effective interest rate method. The 2026 Notes are unsecured and unsubordinated obligations. Interest is payable in cash semi-annually in arrears beginning on February 1, 2020 at a rate of 0.75% per year. The 2026 Notes mature on August 1, 2026 unless repurchased, redeemed, or converted in accordance with the terms prior to such date. The 2026 Notes are convertible into cash, shares of our Class A common stock, or a combination of cash and shares of our Class A common stock, at our election, at an initial conversion rate of 43.8481 shares of Class A common stock per $1,000 principal amount of 2026 Notes, which is equivalent to an initial conversion price of approximately $22.81 per share of our Class A common stock. We may redeem for cash all or portions of the 2026 Notes, at our option, on or after August 6, 2023 based on certain circumstances. Exchange Transactions In 2021, we entered into various exchange agreements (collectively, the “Exchange Agreements”) with certain holders of the 2025 Notes and the 2026 Notes pursuant to which we exchanged approximately $715.9 million principal amount of the 2025 Notes and approximately $426.5 million principal amount of the 2026 Notes for aggregate consideration of approximately 52.4 million shares of Class A common stock (the “Exchange Shares”). The Exchange Shares included an additional 0.7 million shares of our Class A common stock not provided for under the original conversion terms of the 2025 Notes and the 2026 Notes to induce the holders to agree to the exchange. The Exchange Agreements were accounted for as an induced conversion with the fair value of 0.7 million Exchange Shares, less accrued interest, recognized as an inducement expense in other income (expense), net in our consolidated statements of operations and included as an adjustment to reconcile net loss to net cash provided by (used in) operating activities in our consolidated statements of cash flows. Inducement expense recorded for the year ended December 31, 2021 was $41.5 million. The common stock consideration issued under the original terms of the 2025 Notes and 2026 Notes was accounted for under the general conversion accounting guidance with the net carrying amount of $1,132.6 million recorded in additional paid-in-capital and as a non-cash transaction excluded from cash activities on our consolidated statements of cash flows. The Convertible Notes consisted of the following: As of December 31, 2023 2022 Principal Unamortized Debt Issuance Costs Net Carrying Amount Principal Unamortized Debt Issuance Costs Net Carrying Amount (in thousands) 2025 Notes $ 284,105 $ (871) $ 283,234 $ 284,105 $ (1,521) $ 282,584 2026 Notes 838,482 (3,402) 835,080 838,482 (4,698) 833,784 2027 Notes 1,150,000 (7,114) 1,142,886 1,150,000 (9,239) 1,140,761 2028 Notes 1,500,000 (11,800) 1,488,200 1,500,000 (14,609) 1,485,391 Total $ 3,772,587 $ (23,187) $ 3,749,400 $ 3,772,587 $ (30,067) $ 3,742,520 As of December 31, 2023, the debt issuance costs on the 2025 Notes, 2026 Notes, 2027 Notes, and 2028 Notes will be amortized over the remaining period of approximately 1.3 years, 2.6 years, 3.3 years and 4.2 years, respectively. Interest expense related to the amortization of debt issuance costs was $6.9 million, $6.5 million, and $4.3 million for the years ended December 31, 2023, 2022, and 2021, respectively. Contractual interest expense was $8.9 million, $8.7 million, and $8.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. As of December 31, 2023, the if-converted value of the Convertible Notes did not exceed the principal amount. The sale price for conversion was not satisfied as of December 31, 2023 for the Convertible Notes, and as a result, the Convertible Notes will not be eligible for optional conversion during the first quarter of 2024. No sinking fund is provided for the Convertible Notes, which means that we are not required to redeem or retire them periodically. Capped Call Transactions In connection with the pricing of the 2025 Notes, the 2026 Notes, the 2027 Notes, and the 2028 Notes, we entered into the 2025 Capped Call Transactions, the 2026 Capped Call Transactions, the 2027 Capped Call Transactions, and the 2028 Capped Call Transactions (collectively, the “Capped Call Transactions”), respectively, with certain counterparties at a net cost of $100.0 million, $102.1 million, $86.8 million, and $177.0 million, respectively. The cap price of the 2025 Capped Call Transactions, the 2026 Capped Call Transactions, the 2027 Capped Call Transactions, and the 2028 Capped Call Transactions is initially $32.12, $32.58, $121.02, and $93.90 per share of our Class A common stock, respectively. All are subject to certain adjustments under the terms of the Capped Call Transactions. Conditions that cause adjustments to the initial strike price of the Capped Call Transactions mirror conditions that result in corresponding adjustments for the Convertible Notes. The Capped Call Transactions are intended to reduce potential dilution to holders of our Class A common stock beyond the conversion prices up to the cap prices on any conversion of the Convertible Notes or offset any cash payments we are required to make in excess of the principal amount, as the case may be, with such reduction or offset subject to a cap. The cost of the Capped Call Transactions was recorded as a reduction of our additional paid-in capital in our consolidated balance sheets. The Capped Call Transactions will not be remeasured as long as they continue to meet the conditions for equity classification. As of December 31, 2023, the Capped Call Transactions were out-of-the-money. Credit Facility In May 2022, we entered into a five-year senior unsecured revolving credit facility (“Credit Facility”) with certain lenders that allows us to borrow up to $1.05 billion to fund working capital and general corporate-purpose expenditures. Loans bear interest, at our option, at a rate equal to (i) a term secured overnight financing rate (“SOFR”) plus 0.75% or the base rate, if selected by us, for loans made in U.S. dollars, (ii) the Sterling overnight index average plus 0.7826% for loans made in Sterling, or (iii) foreign indices as stated in the credit agreement plus 0.75% for loans made in other permitted foreign currencies. The base rate is defined as the greatest of (i) the Wall Street Journal prime rate, (ii) the greater of the (a) federal funds rate and (b) the overnight bank funding rate, plus 0.50%, and (iii) the applicable SOFR for a period of one month (but not less than zero) plus 1.00. The Credit Facility also contains an annual commitment fee of 0.10% on the daily undrawn balance of the facility. As of December 31, 2023, we had $49.6 million in the form of outstanding standby letters of credit, with no amounts outstanding under the Credit Facility. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Commitments We have non-cancelable contractual agreements primarily related to the hosting of our data processing, storage, and other computing services, as well as lease, content and developer partner, and other commitments. We had $3.0 billion in commitments as of December 31, 2023, primarily due within three years. For additional discussion on leases, see Note 9 to our consolidated financial statements. Contingencies We record a loss contingency when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. We also disclose material contingencies when we believe a loss is not probable but reasonably possible. Accounting for contingencies requires us to use judgment related to both the likelihood of a loss and the estimate of the amount or range of loss. Many legal and tax contingencies can take years to be resolved. Pending Matters In November 2021, we and certain of our officers and directors, were named as defendants in a securities class-action lawsuit purportedly brought on behalf of purchasers of our Class A common stock, alleging that we and certain of our officers made false or misleading statements and omissions concerning the impact that Apple’s App Tracking Transparency framework would have on our business. We believe we have meritorious defenses to this lawsuit and continue to defend the lawsuit vigorously. Based on the preliminary nature of the proceedings in this case, the outcome of this matter remains uncertain. The outcomes of our legal proceedings are inherently unpredictable, subject to significant uncertainties, and could be material to our financial condition, results of operations, and cash flows for a particular period. For the pending matter described above, it is not possible to estimate the reasonably possible loss or range of loss. We are subject to various other legal proceedings and claims in the ordinary course of business, including certain patent, trademark, privacy, regulatory, and employment matters. Although occasional adverse decisions or settlements may occur, we do not believe that the final disposition of any of our other pending matters will seriously harm our business, financial condition, results of operations, and cash flows. Indemnifications In the ordinary course of business, we may provide indemnifications of varying scope and terms to customers, vendors, lessors, investors, directors, officers, employees, and other parties with respect to certain matters. Indemnification may include losses from our breach of such agreements, services we provide, or third-party intellectual property infringement claims. These indemnifications may survive termination of the underlying agreement and the maximum potential amount of future indemnification payments may not be subject to a cap. We have not incurred material costs to defend lawsuits or settle claims related to these indemnifications as of December 31, 2023. We believe the fair value of these liabilities is immaterial and accordingly have no liabilities recorded for these agreements at December 31, 2023. |
Leases
Leases | 12 Months Ended |
Dec. 31, 2023 | |
Leases [Abstract] | |
Leases | Leases We have non-cancelable lease agreements for certain of our offices with original lease terms expiring between 2023 and 2042. Total operating lease costs were $101.0 million, $109.5 million, and $69.8 million for the years ended December 31, 2023, 2022 , and 2021 , respectively. The weighted-average remaining lease term (in years) and discount rate related to the operating leases were as follows: As of December 31, 2023 2022 Weighted-average remaining lease term 10.0 6.8 Weighted-average discount rate 6.1 % 5.0 % The maturities of our operating lease liabilities as of December 31, 2023, were as follows: Operating Leases (in thousands) Year ending December 31, 2024 $ 86,440 2025 72,225 2026 84,100 2027 75,521 2028 72,890 Thereafter 432,152 Total lease payments $ 823,328 Less: Imputed interest (227,728) Present value of lease liabilities $ 595,600 As of December 31, 2023, we had additional operating leases that have not yet commenced for facilities with lease obligations of $70.7 million. These operating leases will commence starting in 2024 with lease terms of approximately 7 years to 11 years. Cash payments included in the measurement of our o perating lease liabilities were $97.7 million, $94.9 million, and $73.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Lease liabilities arising from obtaining operating lease right-of-use assets were $220.2 million, $147.4 million, and $99.3 million for the years ended December 31, 2023, 2022, and 2021, respectively . |
Strategic Investments
Strategic Investments | 12 Months Ended |
Dec. 31, 2023 | |
Equity Method Investments and Joint Ventures [Abstract] | |
Strategic Investments | Strategic Investments We hold strategic investments primarily in privately held companies, which consist of equity securities, and to a lesser extent, debt securities. These strategic investments are primarily recorded at fair value on a non-recurring basis. The estimation of fair value for these privately held strategic investments requires the use of significant unobservable inputs, such as the issuance of new equity by the company, and as a result, we deem these assets as Level 3 financial instruments within the fair value measurement framework. The following table summarizes our strategic investments as of December 31, 2023 and 2022: As of December 31, 2023 2022 (in thousands) Initial cost $ 106,368 $ 125,564 Cumulative upward adjustments 147,317 157,186 Cumulative downward adjustments, including impairments (58,357) (30,411) Carrying value $ 195,328 $ 252,339 Gains and losses recognized during the periods presented were as follows: Year Ended December 31, 2023 2022 2021 (in thousands) Gains (losses) recognized on strategic investments sold during the period, net $ — $ 45,935 $ 27,820 Unrealized gains on strategic investments still held at the reporting date 1,368 19,946 145,010 Unrealized losses, including impairments, on strategic investments still held at the reporting date (28,423) (1,421) (2,854) Gains (losses) on strategic investments, net $ (27,055) $ 64,460 $ 169,976 Gains and losses on all strategic investments are included within other income (expense), net on our consolidated statements of operations and included as an adjustment to reconcile net loss to net cash provided by (used in) operating activities in our consolidated statements of cash flows. Strategic investments are included within other assets on our consolidated balance sheets. |
Fair Value Measurements
Fair Value Measurements | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements Assets and liabilities measured at fair value are classified into the following categories: • Level 1: Quoted market prices in active markets for identical assets or liabilities. • Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. • Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions or external inputs from inactive markets. We classify our cash equivalents and marketable securities within Level 1 or Level 2 because we use quoted market prices or alternative pricing sources and models utilizing market observable inputs to determine their fair value. The following tables set forth our financial assets that are measured at fair value on a recurring basis, excluding publicly traded equity securities, as of December 31, 2023 and 2022: December 31, 2023 Cost or Gross Gross Total Estimated (in thousands) Cash $ 1,780,402 $ — $ — $ 1,780,402 Level 1 securities: U.S. government securities 1,295,918 894 (3,919) 1,292,893 U.S. government agency securities 138,420 31 (188) 138,263 Level 2 securities: Corporate debt securities 234,336 577 (99) 234,814 Commercial paper 65,380 — — 65,380 Certificates of deposit 18,725 — — 18,725 Total $ 3,533,181 $ 1,502 $ (4,206) $ 3,530,477 December 31, 2022 Cost or Gross Gross Total Estimated (in thousands) Cash $ 1,325,946 $ — $ — $ 1,325,946 Level 1 securities: U.S. government securities 1,630,224 109 (9,484) 1,620,849 U.S. government agency securities 175,269 19 (188) 175,100 Level 2 securities: Corporate debt securities 309,942 32 (1,462) 308,512 Commercial paper 290,589 — — 290,589 Certificates of deposit 157,965 — (1) 157,964 Total $ 3,889,935 $ 160 $ (11,135) $ 3,878,960 Gross unrealized losses on marketable debt securities were not material for the years ended December 31, 2023 and 2022. As of December 31, 2023 and 2022, we considered any decreases in fair value on our marketable debt securities to be driven by factors other than credit risk, including market risk. As of December 31, 2023, $760.2 million of our total $1.8 billion in marketable debt securities have contractual maturities between one We hold investments in publicly traded companies with an aggregate carrying value of $13.6 million and $91.5 million as of December 31, 2023 and 2022, respectively, primarily recorded as marketable securities. We classify these publicly traded equity securities within Level 1 because we use quoted market prices to determine their fair value. Gains and losses recognized during the periods presented, which are included within other income (expense), net on our consolidated statements of operations, were as follows: Year Ended December 31, 2023 2022 2021 (in thousands) Gains (losses) recognized on publicly traded equity securities sold during the period, net $ 11,046 $ (22,095) $ — Unrealized gains (losses) on publicly traded equity securities still held at the reporting date, net (17,731) (79,214) 122,064 Gains (losses) on publicly traded equity securities, net $ (6,685) $ (101,309) $ 122,064 We carry the Convertible Notes at face value less the unamortized debt issuance costs on our consolidated balance sheets and present the fair value for disclosure purposes only. As of December 31, 2023, the fair value of the 2025 Notes, the 2026 Notes, the 2027 Notes, and the 2028 Notes was $300.9 million, $893.2 million, $921.5 million, and $1,181.7 million, respectively. As of December 31, 2022, the fair value of the 2025 Notes, the 2026 Notes, the 2027 Notes, and the 2028 Notes was $257.0 million, $711.9 million, $796.2 million, and $1.0 billion, respectively. The estimated fair value of the Convertible Notes, which are classified as Level 2 financial instruments, was determined based on the estimated or actual bid prices of the Convertible Notes in an over-the-counter market on the last business day of the period. |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The domestic and foreign components of pre-tax loss were as follows: Year Ended December 31, 2023 2022 2021 (in thousands) Domestic (1) $ (285,330) $ (538,311) $ 364,989 Foreign (1) (1,009,093) (862,386) (839,360) Loss before income taxes $ (1,294,423) $ (1,400,697) $ (474,371) (1) Includes the impact of intercompany charges to foreign affiliates for financing, management fees, and research and development cost sharing, inclusive of stock-based compensation. The components of our income tax (benefit) expense were as follows: Year Ended December 31, 2023 2022 2021 (in thousands) Current: Federal $ — $ — $ — State 8,585 10,704 919 Foreign 26,727 22,404 22,078 Total current income tax expense (benefit) 35,312 33,108 22,997 Deferred: Federal 1,267 1,212 (6,295) State 1,061 837 (445) Foreign (9,578) (6,201) (2,673) Total deferred income tax expense (benefit) (7,250) (4,152) (9,413) Income tax expense (benefit) $ 28,062 $ 28,956 $ 13,584 The following is a reconciliation of the statutory federal income tax rate to our effective tax rate: Year Ended December 31, 2023 2022 2021 Tax benefit (expense) computed at the federal statutory rate 21.0 % 21.0 % 21.0 % State tax benefit (expense), net of federal benefit (1) 2.2 2.9 31.5 Change in valuation allowance (31.5) (32.0) (246.3) Differences between U.S. and foreign tax rates on foreign income 3.3 2.5 3.9 Stock-based compensation (7.0) (0.1) 119.3 U.S. federal research & development credit benefit 8.6 5.0 36.7 U.K. corporate rate increase — — 39.8 Acquisitions and divestitures 1.8 (0.7) (8.0) Other benefits (expenses) (0.6) (0.7) (0.8) Total income tax benefit (expense) (2.2) % (2.1) % (2.9) % (1) Inclusive of state research and development credits. The significant components of net deferred tax balances were as follows: Year Ended December 31, 2023 2022 (in thousands) Deferred tax assets: Accruals and reserves $ 22,475 $ 37,731 Intangible assets 168,661 177,762 IRC 174 capitalized R&D 449,253 265,485 Stock-based compensation 70,563 102,364 Loss carryforwards 2,774,231 2,651,812 Tax credit carryforwards 969,368 824,220 Lease liability 126,637 98,668 Other 51,764 20,154 Total deferred tax assets 4,632,952 4,178,196 Deferred tax liabilities: Right-of-use asset (111,777) (75,212) Investments (20,183) (30,962) Other (28,416) (17,309) Total deferred tax liabilities (160,376) (123,483) Total net deferred tax assets before valuation allowance 4,472,576 4,054,713 Valuation allowance (4,471,571) (4,060,943) Net deferred taxes $ 1,005 $ (6,230) On December 20, 2021, the Organisation for Economic Co-operation and Development (“OECD”) published Pillar Two Model Rules defining the global minimum tax, which calls for the taxation of large corporations at a minimum rate of 15%. The OECD has since issued administrative guidance providing transition and safe harbor rules around the implementation of the Pillar Two global minimum tax. A number of countries, including the United Kingdom, are currently proposing or have enacted legislation to implement core elements of the Pillar Two proposal by the start of 2024. On February 1, 2023, the FASB indicated that they believe the minimum tax imposed under Pillar Two is an alternative minimum tax, and, accordingly, deferred tax assets and liabilities associated with the minimum tax would not be recognized or adjusted for the estimated future effects of the minimum tax but would be recognized in the period incurred. While we are still closely monitoring developments and evaluating the potential impact on future periods, we do not expect Pillar Two to have a significant impact on our financial results, particularly due to safe harbor relief during the transition period. Beginning January 1, 2022, the Tax Cuts and Jobs Act eliminated the option to currently deduct research and development expenditures in the period incurred and required taxpayers to capitalize and amortize such expenditures over five or fifteen years, as applicable, pursuant to Section 174 of the Internal Revenue Code. Although this tax law change did not result in any U.S. federal tax liability through December 31, 2023 due to the use of existing U.S. federal net operating loss carryforwards, it did result in incremental state tax liability and expense due to limitations on the use of existing state net operating loss carryforwards. On June 10, 2021, the U.K. Finance Act 2021 was enacted, increasing the U.K. tax rate from 19% to 25% effective April 1, 2023. This change in tax rate resulted in a $188.9 million increase to our U.K. net deferred tax assets, which was fully offset by an increase in our valuation allowance, for the period ending December 31, 2021. As of December 31, 2023, we had an immaterial amount of unremitted earnings related to certain foreign subsidiaries. We intend to continue to reinvest these foreign earnings indefinitely and do not expect to incur any significant taxes related to such amounts. As of December 31, 2023, we had accumulated U.S. federal and state net operating loss carryforwards of $6.7 billion and $4.5 billion, respectively. Of the $6.7 billion of federal net operating loss carryforwards, $0.5 billion was generated before January 1, 2018 and is subject to a 20-year carryforward period. The remaining $6.2 billion can be carried forward indefinitely but is subject to an 80% taxable income limitation. The pre-2018 federal and certain significant state net operating loss carryforwards will begin to expire in 2037 and 2031, respectively. As of December 31, 2023, we had $4.5 billion of U.K. net operating loss carryforwards that can be carried forward indefinitely; however, use of such carryforwards in a given year is generally limited to 50% of such year’s taxable income. As of December 31, 2023, we had accumulated U.S. federal and state research tax credits of $816.6 million and $478.9 million, respectively. The U.S. federal research tax credits will begin to expire in 2032. The U.S. state research tax credits do not expire. We recognize valuation allowances on deferred tax assets if it is more likely than not that some or all of the deferred tax assets will not be realized. We had valuation allowances against net deferred tax assets of $4.5 billion and $4.1 billion as of December 31, 2023 and 2022, respectively. In 2023, the increase in the valuation allowance was primarily attributable to a net increase in our deferred tax assets resulting from the loss from operations. Uncertain Tax Positions The following table summarizes the activity related to our gross unrecognized tax benefits for the years ended December 31, 2023, 2022, and 2021: Year Ended December 31, 2023 2022 2021 (in thousands) Beginning balance of unrecognized tax benefits $ 510,669 $ 469,573 $ 344,971 Additions for current year tax positions 46,188 47,366 119,938 Additions for prior year tax positions 10,171 115 180 Reductions for prior year tax positions (16,736) (3,569) (996) Changes due to lapse of statute of limitations (31,786) (1,887) (2,077) Reductions for settlements with taxing authorities (4,927) — — Changes due to foreign currency translation adjustments (175) (929) (357) U.K. corporate rate increase — — 7,914 Ending balance of unrecognized tax benefits (excluding interest and penalties) 513,404 510,669 469,573 Interest and penalties associated with unrecognized tax benefits 967 385 124 Ending balance of unrecognized tax benefits (including interest and penalties) $ 514,371 $ 511,054 $ 469,697 Substantially all of the unrecognized tax benefit was recorded as a reduction in our gross deferred tax assets, offset by a corresponding reduction in our valuation allowance. We have net unrecognized tax benefits of $27.3 million and $21.7 million included in other liabilities on our consolidated balance sheet as of December 31, 2023 and 2022, respectively, which, if recognized, would result in a tax benefit. Our policy is to recognize interest and penalties associated with tax matters as part of the income tax provision and include accrued interest and penalties with the related income tax liability on our consolidated balance sheet. During the year ended December 31, 2023, interest expense recorded related to uncertain tax positions was not material. The income taxes we pay are subject to potential review by taxing jurisdictions globally. Our estimate of the potential outcome of any uncertain tax position is subject to management’s assessment of relevant risks, facts, and circumstances existing at that time. We believe that our estimate has adequately provided for these matters. However, our future results may include adjustments to estimates in the period the audits are resolved, which may impact our effective tax rate. |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Income (Loss) | 12 Months Ended |
Dec. 31, 2023 | |
Accumulated Other Comprehensive Income Loss [Abstract] | |
Accumulated Other Comprehensive Income (Loss) | Accumulated Other Comprehensive Income (Loss) The table below presents the changes in accumulated other comprehensive income (loss) (“AOCI”) by component and the reclassifications out of AOCI: Changes in Accumulated Other Comprehensive Income (Loss) by Component Marketable Foreign Currency Total (in thousands) Balance at December 31, 2022 $ (11,129) $ (2,845) $ (13,974) OCI before reclassifications 8,643 12,836 21,479 Amounts reclassified from AOCI (1) (374) — (374) Net current period OCI 8,269 12,836 21,105 Balance at December 31, 2023 $ (2,860) $ 9,991 $ 7,131 (1) |
Property and Equipment, Net
Property and Equipment, Net | 12 Months Ended |
Dec. 31, 2023 | |
Property, Plant and Equipment [Abstract] | |
Property and Equipment, Net | Property and Equipment, Net Property and equipment, net, consisted of the following: As of December 31, 2023 2022 (in thousands) Computer hardware and software $ 67,989 $ 62,945 Buildings 21,486 21,486 Leasehold improvements 332,721 225,647 Furniture and equipment 162,476 100,025 Construction in progress 90,038 80,267 Total 674,710 490,370 Less: accumulated depreciation and amortization (264,384) (218,593) Property and equipment, net $ 410,326 $ 271,777 Depreciation and amortization expense on property and equipment was $87.3 million, $69.9 million, and $55.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Noncash property and equipment additions in accounts payable, accrued expenses and other current liabilities were $44.5 million, $28.0 million, and $14.2 million as of December 31, 2023, 2022, and 2021, respectively. The following table lists property and equipment, net by geographic area: As of December 31, 2023 2022 (in thousands) United States $ 247,106 $ 214,857 United Kingdom 122,013 36,774 Rest of world (1) 41,207 20,146 Total property and equipment, net $ 410,326 $ 271,777 (1) No individual country exceeded 10% of our total property and equipment, net for any period presented. |
Balance Sheet Components
Balance Sheet Components | 12 Months Ended |
Dec. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Balance Sheet Components | Balance Sheet Components Accrued expenses and other current liabilities at December 31, 2023 and 2022 consisted of the following: As of December 31, 2023 2022 (in thousands) Accrued infrastructure costs $ 281,682 $ 169,886 Partner revenue share liabilities 99,877 83,395 Accrued compensation and related expenses 95,600 206,441 Deferred revenue (1) 93,706 50,782 Other operating costs 75,905 75,376 Acquisition liabilities 7,359 293,332 Other 151,707 108,128 Total accrued expenses and other current liabilities $ 805,836 $ 987,340 (1) We expect a substantial majority of our deferred revenue to be realized in less than one year. |
Employee Benefit Plans
Employee Benefit Plans | 12 Months Ended |
Dec. 31, 2023 | |
Retirement Benefits [Abstract] | |
Employee Benefit Plans | Employee Benefit Plans We have a defined contribution 401(k) plan (the “401(k) Plan”) for our U.S.-based employees. The 401(k) Plan is available for all full-time employees who meet certain eligibility requirements. Eligible employees may contribute up to 100% of their eligible compensation, but are limited to the maximum annual dollar amount allowable under the Code. We match 100% of each participant’s contribution up to a maximum of 3% of the participant’s eligible compensation paid during the period, and also match 50% of each participant’s contribution between 3% and 5% of the participant’s eligible compensation paid during the period. During the years ended December 31, 2023, 2022, and 2021, we recognized expense of $34.0 million, $33.6 million, and $25.0 million, respectively, related to matching contributions. |
Related Party Transactions
Related Party Transactions | 12 Months Ended |
Dec. 31, 2023 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Related Party Transactions In November 2020, we entered into a ground sublease with an entity that is controlled by our CEO that allows us to build and operate a hangar to support our aviation program. This entity subleases the ground to us for $0 and in exchange may utilize a specified percentage of the hangar space. If the entity needs additional space within the hangar, it will pay rent to Snap at a fair market value rate determined at the time this arrangement was entered into. Any space utilized by this entity will be space that is not required for Snap’s aviation program. Subject to certain limited exceptions, neither party may terminate this sublease for at least six years. After this period, Snap or this entity may terminate the lease at any time on 24 months’ prior written notice. Upon termination of the sublease, this entity will purchase the hangar from Snap at its fair market value on the termination date. The value of these arrangements is not material to our consolidated financial statements for the periods presented or for the term of the agreement. |
Restructuring
Restructuring | 12 Months Ended |
Dec. 31, 2023 | |
Restructuring and Related Activities [Abstract] | |
Restructuring | Restructuring AR Enterprise Strategic Review In the third quarter of 2023, we initiated the wind down of our AR Enterprise business, which included a reduction of our global employee headcount by approximately 3%. We substantially completed the program in the fourth quarter of 2023. During the year ended December 31, 2023, we recognized pre-tax restructuring charges of $40.8 million, primarily recorded in sales and marketing and general and administrative expenses in our consolidated statement of operations, and an income tax benefit of $5.7 million. The pre-tax restructuring charges primarily include cash severance, stock-based compensation expense, and charges related to the revision of the useful lives and disposal of certain acquired intangible assets. Strategic Reprioritization In the third quarter of 2022, we initiated a strategic reprioritization plan, which included a reduction of our global employee headcount by approximately 20%. We substantially completed the reprioritization plan in the fourth quarter of 2022. The following table summarizes the restructuring charges (benefits) in our consolidated statements of operations for the year ended December 31, 2022: Severance and Related Charges (1) Stock-Based Compensation Expense (Benefit) Lease Exit and Related Charges (2) Other (3) Total (in thousands) Cost of revenue $ 2,291 $ 709 $ — $ 17,585 $ 20,585 Research and development 46,994 29,188 — 2,733 78,915 Sales and marketing 30,565 (504) — 730 30,791 General and administrative 17,211 5,111 31,227 5,109 58,658 Total $ 97,061 $ 34,504 $ 31,227 $ 26,157 $ 188,949 (1) Severance and related charges include cash severance expense and other termination benefits. The majority of cash paid for restructuring in 2022 was related to severance and benefits. (2) Lease exit and related charges are non-cash and presented in other cash flows from operating activities in our consolidated statements of cash flows. (3) Other includes impairment charges, contract termination charges, and intangible asset amortization. The liabilities related to the strategic reprioritization plan were immaterial as of December 31, 2023 and 2022. |
Subsequent Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2023 | |
Subsequent Events [Abstract] | |
Subsequent Events | Subsequent Events On February 5, 2024, we announced a plan to reduce our global headcount by approximately 10% of our global full-time employees. As a result, we currently estimate that we will incur pre-tax charges in the range of $55 million to $75 million, primarily consisting of severance and related costs, and other charges, of which $45 million to $55 million are expected to be future cash expenditures. The majority of these costs are expected to be incurred during the first quarter of 2024. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Pay vs Performance Disclosure | |||
Net loss | $ (1,322,485) | $ (1,429,653) | $ (487,955) |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended | 12 Months Ended |
Dec. 31, 2023 shares | Dec. 31, 2023 shares | |
Trading Arrangements, by Individual | ||
Material Terms of Trading Arrangement | During the quarter ended December 31, 2023, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions, or written plans for the purchase or sale of our securities set forth in the table below: Type of Trading Arrangement Name and Position Date Action Rule 10b5-1 (1) Expiration Date Total Shares of Class A Common Stock to be Sold Michael O'Sullivan, General Counsel 11/20/2023 Adoption X 1/31/2025 216,160 (1) Contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. | |
Non-Rule 10b5-1 Arrangement Adopted | false | |
Rule 10b5-1 Arrangement Terminated | false | |
Non-Rule 10b5-1 Arrangement Terminated | false | |
Michael O'Sullivan [Member] | ||
Trading Arrangements, by Individual | ||
Name | Michael O'Sullivan | |
Title | General Counsel | |
Rule 10b5-1 Arrangement Adopted | true | |
Adoption Date | 11/20/2023 | |
Arrangement Duration | 438 days | |
Aggregate Available | 216,160 | 216,160 |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation Our consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Our consolidated financial statements include the accounts of Snap Inc. and our wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Our fiscal year ends on December 31. Certain reclassifications have been made in the prior periods to conform to the current year's presentation. None of these reclassifications had a material impact on our consolidated financial statements. |
Use of Estimates | Use of Estimates The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements. Management’s estimates are based on historical information available as of the date of the consolidated financial statements and various other assumptions that we believe are reasonable under the circumstances. Actual results could differ from those estimates. Key estimates relate primarily to determining the fair value of assets and liabilities assumed in business combinations, evaluation of contingencies, uncertain tax positions, and the fair value of strategic investments. On an ongoing basis, management evaluates our estimates compared to historical experience and trends, which form the basis for making judgments about the carrying value of assets and liabilities. |
Concentrations of Business Risk | Concentrations of Business Risk We currently use both Google Cloud and Amazon Web Services for our hosting requirements. A disruption or loss of service from one or both of these partners could seriously harm our ability to operate. Although we believe there are other qualified providers that can provide these services, a transition to a new provider could create a significant disruption to our business and negatively impact our consolidated financial statements. |
Concentrations of Credit Risk | Concentrations of Credit Risk Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash, cash equivalents, marketable securities, and accounts receivable. We maintain cash deposits, cash equivalent balances, and marketable securities with several financial institutions. Cash and cash equivalents may be withdrawn or redeemed on demand. We believe that the financial institutions that hold our cash and cash equivalents are financially sound and, accordingly, minimal credit risk exists with respect to these balances. We also maintain investments in U.S. government debt and agency securities, publicly traded equity securities, corporate debt securities, certificates of deposit, and commercial paper that carry high credit ratings and accordingly, minimal credit risk exists with respect to these balances. We extend credit to our customers based on an evaluation of their ability to pay amounts due under contractual arrangement and generally do not obtain or require collateral. |
Revenue Recognition | Revenue Recognition Revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to receive in exchange for those goods or services. See Note 2 for additional information. |
Cost of Revenue | Cost of Revenue Cost of revenue In addition, cost of revenue consists of payments to third-party infrastructure partners for hosting our products, which include expenses related to storage, computing, and bandwidth costs. Cost of revenue also includes third-party selling costs, personnel-related costs, facilities and other supporting overhead costs, including depreciation and amortization, and inventory costs. |
Advertising | Advertising Advertising costs are expensed as incurred and were $24.9 million, $42.7 million, and $62.4 million for the years ended December 31, 2023, 2022, and 2021, respectively. |
Capital Structure | Capital Structure |
Future Stock Split to be Effected in the Form of a Stock Dividend | Future Stock Split to be Effected in the Form of a Stock Dividend In July 2022, our board of directors determined that it was advisable and in our best interest to approve a stock split to be effected in the form of a special dividend of one share of Class A common stock on each outstanding share of our common stock at a future date (the “Future Stock Split”). In connection with the Future Stock Split, we entered into certain agreements (the “Co-Founder Agreements”) with Evan Spiegel and Robert Murphy, our co-founders, and certain of their respective affiliates requiring them, among other things, to convert shares of Class B common stock and Class C common stock into Class A common stock under certain circumstances. The Future Stock Split will not be declared and paid until the first business day following the date on which the average of the volume weighted average price (the “VWAP”) per share of Class A common stock equals or exceeds $40 per share for 65 consecutive trading days. If this does not occur by July 21, 2032, the Future Stock Split will not be declared and paid, and the Co-Founder Agreements will terminate. In June 2023, in connection with a proposed settlement of a class-action lawsuit, and as amended in December 2023, we agreed to modify the conditions for the Future Stock Split, subject to various conditions, including judicial approval of the settlement. If approved, the Future Stock Split will not be declared and paid until the first business day following the date on which (i) the VWAP per share of Class A common stock equals or exceeds $40 per share for 90 consecutive trading days (the “90-Day VWAP”) and (ii) the ratio of the 90-Day VWAP to $8.70 equals or exceeds the ratio of the average closing price of the S&P 500 Total Return index for the same 90 trading days for which the 90-Day VWAP was calculated to 8,862.85. The original ten year time period to trigger the Future Stock Split would remain unchanged. No adjustments have been made to share or per share amounts for Class A common stock in the accompanying consolidated financial statements for the effects of the Future Stock Split as these triggering conditions have not been met. |
Stock-based Compensation | Stock-based Compensation We measure and recognize compensation expense for stock-based payment awards, including stock options, restricted stock units (“RSUs”), and restricted stock awards (“RSAs”) granted to employees, directors, and advisors, based on the grant date fair value of the awards. The grant date fair value of stock options is estimated using a Black-Scholes option pricing model. The fair value of stock-based compensation for stock options is recognized on a straight-line basis, net of estimated forfeitures, over the period during which services are provided in exchange for the award. The grant date fair value of RSUs and RSAs is estimated based on the fair value of our underlying common stock. RSUs and RSAs vest on the satisfaction of a service-based condition. The service condition for RSUs and RSAs is generally satisfied in equal monthly or quarterly installments over three eriod. Stock-based compensation expense recognized for all periods presented is based on awards that are expected to vest, including an estimate of forfeitures. We estimate the forfeiture rate using historical forfeitures of equity awards and other expected changes in facts and circumstances, if any. A modification of the terms of a stock-based award is treated as an exchange of the original award for a new award with total compensation cost equal to the grant-date fair value of the original award plus the incremental value of the modification to the award. The future tax benefits on settlement of the above RSUs and RSAs is not expected to be material as currently we have established valuation allowances to reduce our net deferred tax assets to the amount that is more likely than not to be realized. The majority of the future tax benefits that arise on settlement of the above RSUs are in jurisdictions for which our net deferred tax assets have a full valuation allowance. |
Income Taxes | Income Taxes We are subject to income taxes in the United States and numerous foreign jurisdictions. Deferred tax assets and liabilities are determined based on differences between the financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the deferred tax asset or liability is expected to be realized or settled. In evaluating our ability to recover deferred tax assets, we consider all available positive and negative evidence, including historical operating results, ongoing tax planning, and forecasts of future taxable income on a jurisdiction-by-jurisdiction basis. Based on the level of historical losses, we have established a valuation allowance to reduce our net deferred tax assets to the amount that is more likely than not to be realized. We recognize a tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in our consolidated financial statements from such positions are measured based on the largest benefit that has a greater than 50% likelihood of being realized. We recognize interest and penalties associated with tax matters as part of the income tax provision and include accrued interest and penalties with the related income tax liability on our consolidated balance sheets. |
Currency Translation and Remeasurement | Currency Translation and Remeasurement The functional currency of the majority of our foreign subsidiaries is the U.S. dollar. Monetary assets and liabilities denominated in a foreign currency are remeasured into U.S. dollars at the exchange rate on the balance sheet date. Revenue and expenses are remeasured at the average exchange rates during the period. Equity transactions and other non-monetary assets are remeasured using historical exchange rates. Foreign currency transaction gains and losses are recorded in other income (expense), net on our consolidated statement of operations. For those foreign subsidiaries where the local currency is the functional currency, adjustments to translate those statements into U.S. dollars are recorded in accumulated other comprehensive income (loss) in stockholders’ equity. |
Cash and Cash Equivalents | Cash and Cash Equivalents Cash and cash equivalents consist of highly liquid investments with original maturities of 90 days or less from the date of purchase. |
Restricted Cash | Restricted Cash |
Marketable Securities | Marketable Securities We hold investments in marketable securities consisting of U.S. government securities, U.S. government agency securities, publicly traded equity securities, corporate debt securities, certificates of deposit, and commercial paper. We classify marketable investments in debt securities as available-for-sale investments in our current assets because they represent investments available for current operations. Our available-for-sale investments in debt securities are carried at fair value with any unrealized gains and losses, included in accumulated other comprehensive (loss) income in stockholders’ equity. Available-for-sale debt securities with an amortized cost basis in excess of estimated fair value are assessed to determine what amount of that difference, if any, is caused by expected credit losses, with any allowance for credit losses recognized as a charge in other income (expense), net on our consolidated statements of income. We did not record any credit losses on our available-for-sale debt securities in any of the periods presented. We determine gains or losses on the sale or maturities of marketable securities using the specific identification method and these gains or losses are recorded in other income (expense), net in our consolidated statements of operations. Publicly traded equity securities are carried at fair value with any unrealized gains and losses recorded in other income (expense), net in our consolidated statements of operations. |
Strategic Investments | Strategic Investments We hold strategic investments primarily in privately held companies, consisting primarily of equity securities without readily determinable fair values, and to a lesser extent, debt securities. We adjust the carrying value of these equity securities to fair value upon observable transactions for identical or similar investments of the same issuer or upon impairment. All strategic investments are reviewed periodically for impairment. Any adjustments to carrying value of these investments are recorded in other income (expense), net in our consolidated statements of operations. Strategic investments are included within other assets in our consolidated balance sheets. When we exercise significant influence over, but do not control the investee, such strategic investments are accounted for using the equity method. Under the equity method of accounting, we record our share of the results of the investments within other income (expense), net in our consolidated statements of operations. |
Fair Value Measurements | Fair Value Measurements Certain financial instruments are required to be recorded at fair value. Other financial instruments, including cash and cash equivalents and restricted cash, are recorded at cost, which approximates fair value. Additionally, accounts receivable, accounts payable, and accrued expenses approximate fair value because of the short-term nature of these financial instruments. |
Accounts Receivable and Allowance for Doubtful Accounts | Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are recorded at the invoiced amount less any allowance for doubtful accounts to reserve for potentially uncollectible receivables. To determine the amount of the allowance, we make judgments about the creditworthiness of customers based on ongoing credit evaluation and historical experience. At December 31, 2023 and 2022, the allowance for doubtful accounts was immaterial. |
Property and Equipment | Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. We compute depreciation using the straight-line method over the estimated useful lives of the assets, which is generally three years for computer hardware, software, and equipment, five years for furniture, and over the shorter of lease term or useful life of the assets for leasehold improvements. Buildings are generally depreciated over a useful life ranging from 20 to 45 years. Maintenance and repairs are expensed as incurred. |
Leases | Leases We have non-cancelable lease agreements for primarily offices that are recorded as operating lease right-of-use assets and operating lease liabilities in our consolidated balance sheets. We account for lease and non-lease components as a single lease component and do not record leases with an initial term of twelve months or less in our consolidated balance sheets. We use our incremental borrowing rate based on the information available at the lease commencement date to determine the present value of lease payments over the lease term . Our lease terms may include options to extend or terminate the lease when it is reasonably certain we will exercise that option. Certain agreements have free rent periods or escalating rent payment provisions. Rent expense is recognized on a straight-line basis over the lease term. |
Software Development Costs | Software Development Costs Software development costs include costs to develop software to be used to meet internal needs and applications used to deliver our services. We capitalize development costs related to these software applications once the preliminary project stage is complete and it is probable that the project will be completed and the software will be used to perform the function intended. Costs capitalized for developing such software applications were not material for the periods presented. |
Segments | Segments Our CEO is our chief operating decision maker ( “ CODM ” ). We have determined that we have a single operating segment. Our CEO evaluates performance and makes operating decisions about allocating resources based on financial data presented on a consolidated basis accompanied by disaggregated information about revenue by geographic region. |
Business Combinations | Business Combinations We include the results of operations of the businesses that we acquire from the date of acquisition. We determine the fair value of the assets acquired and liabilities assumed based on their estimated fair values as of the respective date of acquisition. The excess purchase price over the fair values of identifiable assets and liabilities is recorded as goodwill. Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates including the selection of valuation methodologies, estimates of future revenue and cash flows, discount rates, and selection of comparable companies. Our estimates of fair value are based on assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, not to exceed one year from the date of acquisition, we may record adjustments to the assets acquired and liabilities assumed, with a corresponding offset to goodwill. At the conclusion of the measurement period, any subsequent adjustments are reflected in our consolidated statements of operations. When we issue payments or grants of equity to selling stockholders in connection with an acquisition, we evaluate whether the payments or awards are compensatory. This evaluation includes whether cash payments or stock award vesting is contingent on the continued employment of the selling stockholder beyond the acquisition date. If continued employment is required for the cash to be paid or stock awards to vest, the award is treated as compensation for post-acquisition services and is recognized as compensation expense. Transaction costs associated with business combinations are expensed as incurred, and are included in general and administrative expenses in our consolidated statements of operations. |
Goodwill | Goodwill Goodwill represents the excess of the purchase price over the fair value of net assets acquired in a business combination. We test goodwill for impairment at least annually, in the fourth quarter, or whenever events or changes in circumstances indicate that goodwill might be impaired. For all periods presented, we had a single operating segment and reporting unit structure. There were no impairment charges in any of the periods presented. |
Intangible Assets | Intangible Assets Intangible assets are carried at cost and amortized on a straight-line basis over their estimated useful lives. We determine the appropriate useful life of our intangible assets by measuring the expected cash flows of acquired assets. The estimated useful lives of intangible assets are generally as follows: Intangible Asset Estimated Useful Domain names 5 Years Trademarks 3 Years Acquired developed technology 3 to 7 Years Customer relationships 2 to 8 Years Patents 4 to 14 Years |
Impairment of Long-Lived Assets | Impairment of Long-Lived Assets We evaluate recoverability of our property and equipment and intangible assets, excluding goodwill, when events or changes indicate the carrying amount of an asset may not be recoverable. Events and changes in circumstances considered in determining whether the carrying value of long-lived assets may not be recoverable include: significant changes in performance relative to expected operating results; significant changes in asset use; and significant negative industry or economic trends and changes in our business strategy. Recoverability of these assets is measured by comparison of their carrying amount to future undiscounted cash flows to be generated. If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. |
Legal Contingencies | Legal Contingencies For legal contingencies, we accrue a liability for an estimated loss if the potential loss from any claim or legal proceeding is considered probable, and the amount can be reasonably estimated. Legal fees and expenses are expensed as incurred. Note 8 provides additional information regarding our legal contingencies. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities to provide greater disaggregation within their annual rate reconciliation, including new requirements to present reconciling items on a gross basis in specified categories, disclose both percentages and dollar amounts, and disaggregate individual reconciling items by jurisdiction and nature when the effect of the items meet a quantitative threshold. The guidance also requires disaggregating the annual disclosure of income taxes paid, net of refunds received, by federal (national), state, and foreign taxes, with separate presentation of individual jurisdictions that meet a quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024 on a prospective basis, with a retrospective option, and early adoption is permitted. We are currently evaluating the impact of adoption of this standard on our consolidated financial statements and disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities with a single reportable segment to provide all the disclosures required by this standard and all existing segment disclosures in Topic 280 on an interim and annual basis, including new requirements to disclose significant segment expenses that are regularly provided to the CODM and included within the reported measure(s) of a segment's profit or loss, the amount and composition of any other segment items, the title and position of the CODM, and how the CODM uses the reported measure(s) of a segment's profit or loss to assess performance and decide how to allocate resources. The guidance is effective for annual periods beginning after December 15, 2023, and interim periods beginning after December 15, 2024, applied retrospectively with early adoption permitted. We are currently evaluating the impact of adoption of this standard on our consolidated financial statements and disclosures. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Summary of Estimated Useful Lives of Intangible Assets | The estimated useful lives of intangible assets are generally as follows: Intangible Asset Estimated Useful Domain names 5 Years Trademarks 3 Years Acquired developed technology 3 to 7 Years Customer relationships 2 to 8 Years Patents 4 to 14 Years Intangible assets consisted of the following: December 31, 2023 Weighted- Gross Accumulated Net (in thousands, except years) Domain names 3.0 $ 745 $ (546) $ 199 Technology 2.8 323,313 (197,608) 125,705 Patents 8.8 39,373 (19,099) 20,274 Other — 6,000 (5,875) 125 $ 369,431 $ (223,128) $ 146,303 December 31, 2022 Weighted- Gross Accumulated Net (in thousands, except years) Domain names 4.0 $ 954 $ (690) $ 264 Trademarks 1.2 800 (478) 322 Technology 3.1 340,375 (178,427) 161,948 Customer relationships 5.7 21,000 (6,641) 14,359 Patents 9.1 39,373 (14,912) 24,461 Other 1.0 6,000 (2,874) 3,126 $ 408,502 $ (204,022) $ 204,480 |
Revenue (Tables)
Revenue (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Revenue Disaggregated by Geography | The following table represents our revenue disaggregated by geography based on the billing address of the customer: Year Ended December 31, 2023 2022 2021 (in thousands) North America (1) (2) $ 2,952,301 $ 3,205,554 $ 2,871,369 Europe (3) 772,078 712,764 660,473 Rest of world 881,736 683,529 585,206 Total revenue $ 4,606,115 $ 4,601,847 $ 4,117,048 (1) North America includes Mexico, the Caribbean, and Central America. (2) United States revenue was $2.9 billion, $3.1 billion, and $2.8 billion for the years ended December 31, 2023, 2022, and 2021, respectively. (3) Europe includes Russia and Turkey. Effective March 2022, we halted advertising sales to Russian and Belarusian entities. |
Net Loss per Share (Tables)
Net Loss per Share (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Earnings Per Share [Abstract] | |
Schedule of Numerators and Denominators of Basic and Diluted Net Loss per Share Computations for Common Stock | The numerators and denominators of the basic and diluted net loss per share computations for our common stock are calculated as follows for the years ended December 31, 2023, 2022, and 2021: Year Ended December 31, 2023 2022 2021 (in thousands, except per share data) Class A Class B Class C Class A Class B Class C Class A Class B Class C Numerator: Net loss $ (1,114,039) $ (18,479) $ (189,967) $ (1,203,614) $ (20,141) $ (205,898) $ (408,118) $ (7,339) $ (72,498) Net loss attributable to common stockholders $ (1,114,039) $ (18,479) $ (189,967) $ (1,203,614) $ (20,141) $ (205,898) $ (408,118) $ (7,339) $ (72,498) Denominator: Basic shares: Weighted-average common shares - Basic 1,358,345 22,532 231,627 1,354,019 22,658 231,627 1,303,921 23,449 231,627 Diluted shares: Weighted-average common shares - Diluted 1,358,345 22,532 231,627 1,354,019 22,658 231,627 1,303,921 23,449 231,627 Net loss per share attributable to common stockholders: Basic $ (0.82) $ (0.82) $ (0.82) $ (0.89) $ (0.89) $ (0.89) $ (0.31) $ (0.31) $ (0.31) Diluted $ (0.82) $ (0.82) $ (0.82) $ (0.89) $ (0.89) $ (0.89) $ (0.31) $ (0.31) $ (0.31) |
Schedule of Potentially Dilutive Shares Excluded from Calculation of Diluted Net Loss per Share | The following potentially dilutive shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented: Year Ended December 31, 2023 2022 2021 (in thousands) Stock options 1,697 3,159 4,304 Unvested RSUs and RSAs 157,130 132,392 86,180 Convertible Notes (if-converted) 89,379 89,379 62,755 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Summary of RSU and RSA Award Activity | The following table summarizes the RSU and RSA activity during the year ended December 31, 2023: Class A Weighted- (in thousands, except per share data) Unvested at December 31, 2022 132,392 $ 18.28 Granted 148,701 $ 10.41 Vested (91,641) $ 15.71 Forfeited (32,322) $ 15.90 Unvested at December 31, 2023 157,130 $ 12.82 |
Summary of Stock Option Award Activity | The following table summarizes the stock option award activity under the Stock Plans during the year ended December 31, 2023: Class A Class B Weighted- Weighted- Aggregate Intrinsic Value (1) (in thousands, except per share data) Outstanding at December 31, 2022 2,589 570 $ 9.68 4.05 $ 9,669 Granted — — $ — Exercised (599) (565) $ 0.89 Forfeited (298) — $ 14.27 Outstanding at December 31, 2023 1,692 5 $ 14.90 4.41 $ 5,225 Exercisable at December 31, 2023 1,692 5 $ 14.90 4.41 $ 5,225 Vested and expected to vest at December 31, 2023 1,692 5 $ 14.90 4.41 $ 5,225 (1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock option awards and the closing market price of our Class A common stock as of December 31, 2023 and December 31, 2022, respectively. |
Summary of Total Stock-based Compensation Expense | Total stock-based compensation expense by function was as follows: Year Ended December 31, 2023 2022 2021 (in thousands) Cost of revenue $ 9,555 $ 12,288 $ 17,221 Research and development 893,026 970,746 740,130 Sales and marketing 255,688 203,092 164,241 General and administrative 165,735 201,661 170,543 Total $ 1,324,004 $ 1,387,787 $ 1,092,135 |
Business Acquisitions (Tables)
Business Acquisitions (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Wave Optics | |
Business Acquisition [Line Items] | |
Summary of Total Purchase Consideration Allocation | The allocation of the total purchase consideration for this acquisition was as follows: Total (in thousands) Trademarks $ 20,584 Technology 77,118 Customer relationships 32,708 Goodwill 370,236 Net deferred tax liability (3,313) Other assets acquired and liabilities assumed, net 13,111 Total $ 510,444 |
Fit Analytics | |
Business Acquisition [Line Items] | |
Summary of Total Purchase Consideration Allocation | The allocation of the total purchase consideration for this acquisition was as follows: Total (in thousands) Trademarks $ 800 Technology 17,000 Customer relationships 17,000 Goodwill 88,132 Net deferred tax liability (5,643) Other assets acquired and liabilities assumed, net 7,160 Total $ 124,449 |
Other Acquisitions | |
Business Acquisition [Line Items] | |
Summary of Total Purchase Consideration Allocation | The aggregate allocation of purchase consideration was as follows: Total (in thousands) Technology $ 64,150 Customer relationships 4,000 Goodwill 203,482 Net deferred tax liability (11,871) Other assets acquired and liabilities assumed, net 6,325 Total $ 266,086 |
Goodwill and Intangible Assets
Goodwill and Intangible Assets (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Changes in Carrying Amount of Goodwill | The changes in the carrying amount of goodwill for the years ended December 31, 2023 and 2022 were as follows: Goodwill (in thousands) Balance as of December 31, 2021 $ 1,588,452 Goodwill acquired 69,291 Foreign currency translation (11,623) Balance as of December 31, 2022 $ 1,646,120 Goodwill acquired 42,780 Foreign currency translation 2,927 Balance as of December 31, 2023 $ 1,691,827 |
Summary of Estimated Useful Lives of Intangible Assets | The estimated useful lives of intangible assets are generally as follows: Intangible Asset Estimated Useful Domain names 5 Years Trademarks 3 Years Acquired developed technology 3 to 7 Years Customer relationships 2 to 8 Years Patents 4 to 14 Years Intangible assets consisted of the following: December 31, 2023 Weighted- Gross Accumulated Net (in thousands, except years) Domain names 3.0 $ 745 $ (546) $ 199 Technology 2.8 323,313 (197,608) 125,705 Patents 8.8 39,373 (19,099) 20,274 Other — 6,000 (5,875) 125 $ 369,431 $ (223,128) $ 146,303 December 31, 2022 Weighted- Gross Accumulated Net (in thousands, except years) Domain names 4.0 $ 954 $ (690) $ 264 Trademarks 1.2 800 (478) 322 Technology 3.1 340,375 (178,427) 161,948 Customer relationships 5.7 21,000 (6,641) 14,359 Patents 9.1 39,373 (14,912) 24,461 Other 1.0 6,000 (2,874) 3,126 $ 408,502 $ (204,022) $ 204,480 |
Schedule of Estimated Intangible Asset Amortization Expense | As of December 31, 2023, the estimated intangible asset amortization expense for the next five years and thereafter is as follows: Estimated (in thousands) Year ending December 31, 2024 $ 58,532 2025 42,513 2026 20,776 2027 12,104 2028 4,323 Thereafter 8,055 Total $ 146,303 |
Long-Term Debt (Tables)
Long-Term Debt (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Summary of Convertible Notes | The Convertible Notes consisted of the following: As of December 31, 2023 2022 Principal Unamortized Debt Issuance Costs Net Carrying Amount Principal Unamortized Debt Issuance Costs Net Carrying Amount (in thousands) 2025 Notes $ 284,105 $ (871) $ 283,234 $ 284,105 $ (1,521) $ 282,584 2026 Notes 838,482 (3,402) 835,080 838,482 (4,698) 833,784 2027 Notes 1,150,000 (7,114) 1,142,886 1,150,000 (9,239) 1,140,761 2028 Notes 1,500,000 (11,800) 1,488,200 1,500,000 (14,609) 1,485,391 Total $ 3,772,587 $ (23,187) $ 3,749,400 $ 3,772,587 $ (30,067) $ 3,742,520 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Leases [Abstract] | |
Summary of Weighted-average Remaining Lease Term and Discount Rate Related to Operating Leases | The weighted-average remaining lease term (in years) and discount rate related to the operating leases were as follows: As of December 31, 2023 2022 Weighted-average remaining lease term 10.0 6.8 Weighted-average discount rate 6.1 % 5.0 % |
Schedule of Present Value of Operating Lease Liabilities | The maturities of our operating lease liabilities as of December 31, 2023, were as follows: Operating Leases (in thousands) Year ending December 31, 2024 $ 86,440 2025 72,225 2026 84,100 2027 75,521 2028 72,890 Thereafter 432,152 Total lease payments $ 823,328 Less: Imputed interest (227,728) Present value of lease liabilities $ 595,600 |
Strategic Investments (Tables)
Strategic Investments (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Equity Method Investments and Joint Ventures [Abstract] | |
Summary of Strategic Investments | The following table summarizes our strategic investments as of December 31, 2023 and 2022: As of December 31, 2023 2022 (in thousands) Initial cost $ 106,368 $ 125,564 Cumulative upward adjustments 147,317 157,186 Cumulative downward adjustments, including impairments (58,357) (30,411) Carrying value $ 195,328 $ 252,339 |
Summary of Gain (Loss) on Strategic Investments | Gains and losses recognized during the periods presented were as follows: Year Ended December 31, 2023 2022 2021 (in thousands) Gains (losses) recognized on strategic investments sold during the period, net $ — $ 45,935 $ 27,820 Unrealized gains on strategic investments still held at the reporting date 1,368 19,946 145,010 Unrealized losses, including impairments, on strategic investments still held at the reporting date (28,423) (1,421) (2,854) Gains (losses) on strategic investments, net $ (27,055) $ 64,460 $ 169,976 Gains and losses recognized during the periods presented, which are included within other income (expense), net on our consolidated statements of operations, were as follows: Year Ended December 31, 2023 2022 2021 (in thousands) Gains (losses) recognized on publicly traded equity securities sold during the period, net $ 11,046 $ (22,095) $ — Unrealized gains (losses) on publicly traded equity securities still held at the reporting date, net (17,731) (79,214) 122,064 Gains (losses) on publicly traded equity securities, net $ (6,685) $ (101,309) $ 122,064 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Summary of Financial Assets Measured at Fair Value on Recurring Basis | The following tables set forth our financial assets that are measured at fair value on a recurring basis, excluding publicly traded equity securities, as of December 31, 2023 and 2022: December 31, 2023 Cost or Gross Gross Total Estimated (in thousands) Cash $ 1,780,402 $ — $ — $ 1,780,402 Level 1 securities: U.S. government securities 1,295,918 894 (3,919) 1,292,893 U.S. government agency securities 138,420 31 (188) 138,263 Level 2 securities: Corporate debt securities 234,336 577 (99) 234,814 Commercial paper 65,380 — — 65,380 Certificates of deposit 18,725 — — 18,725 Total $ 3,533,181 $ 1,502 $ (4,206) $ 3,530,477 December 31, 2022 Cost or Gross Gross Total Estimated (in thousands) Cash $ 1,325,946 $ — $ — $ 1,325,946 Level 1 securities: U.S. government securities 1,630,224 109 (9,484) 1,620,849 U.S. government agency securities 175,269 19 (188) 175,100 Level 2 securities: Corporate debt securities 309,942 32 (1,462) 308,512 Commercial paper 290,589 — — 290,589 Certificates of deposit 157,965 — (1) 157,964 Total $ 3,889,935 $ 160 $ (11,135) $ 3,878,960 |
Summary of Gain (Loss) on Strategic Investments | Gains and losses recognized during the periods presented were as follows: Year Ended December 31, 2023 2022 2021 (in thousands) Gains (losses) recognized on strategic investments sold during the period, net $ — $ 45,935 $ 27,820 Unrealized gains on strategic investments still held at the reporting date 1,368 19,946 145,010 Unrealized losses, including impairments, on strategic investments still held at the reporting date (28,423) (1,421) (2,854) Gains (losses) on strategic investments, net $ (27,055) $ 64,460 $ 169,976 Gains and losses recognized during the periods presented, which are included within other income (expense), net on our consolidated statements of operations, were as follows: Year Ended December 31, 2023 2022 2021 (in thousands) Gains (losses) recognized on publicly traded equity securities sold during the period, net $ 11,046 $ (22,095) $ — Unrealized gains (losses) on publicly traded equity securities still held at the reporting date, net (17,731) (79,214) 122,064 Gains (losses) on publicly traded equity securities, net $ (6,685) $ (101,309) $ 122,064 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Schedule of Domestic and Foreign Components of Pre-Tax Loss | The domestic and foreign components of pre-tax loss were as follows: Year Ended December 31, 2023 2022 2021 (in thousands) Domestic (1) $ (285,330) $ (538,311) $ 364,989 Foreign (1) (1,009,093) (862,386) (839,360) Loss before income taxes $ (1,294,423) $ (1,400,697) $ (474,371) (1) Includes the impact of intercompany charges to foreign affiliates for financing, management fees, and research and development cost sharing, inclusive of stock-based compensation. |
Schedule of Components of Income Tax (Benefit) Expense | The components of our income tax (benefit) expense were as follows: Year Ended December 31, 2023 2022 2021 (in thousands) Current: Federal $ — $ — $ — State 8,585 10,704 919 Foreign 26,727 22,404 22,078 Total current income tax expense (benefit) 35,312 33,108 22,997 Deferred: Federal 1,267 1,212 (6,295) State 1,061 837 (445) Foreign (9,578) (6,201) (2,673) Total deferred income tax expense (benefit) (7,250) (4,152) (9,413) Income tax expense (benefit) $ 28,062 $ 28,956 $ 13,584 |
Summary of Reconciliation of Statutory Federal Income Tax Rate | The following is a reconciliation of the statutory federal income tax rate to our effective tax rate: Year Ended December 31, 2023 2022 2021 Tax benefit (expense) computed at the federal statutory rate 21.0 % 21.0 % 21.0 % State tax benefit (expense), net of federal benefit (1) 2.2 2.9 31.5 Change in valuation allowance (31.5) (32.0) (246.3) Differences between U.S. and foreign tax rates on foreign income 3.3 2.5 3.9 Stock-based compensation (7.0) (0.1) 119.3 U.S. federal research & development credit benefit 8.6 5.0 36.7 U.K. corporate rate increase — — 39.8 Acquisitions and divestitures 1.8 (0.7) (8.0) Other benefits (expenses) (0.6) (0.7) (0.8) Total income tax benefit (expense) (2.2) % (2.1) % (2.9) % (1) Inclusive of state research and development credits. |
Summary of Significant Components of Net Deferred Tax Balances | The significant components of net deferred tax balances were as follows: Year Ended December 31, 2023 2022 (in thousands) Deferred tax assets: Accruals and reserves $ 22,475 $ 37,731 Intangible assets 168,661 177,762 IRC 174 capitalized R&D 449,253 265,485 Stock-based compensation 70,563 102,364 Loss carryforwards 2,774,231 2,651,812 Tax credit carryforwards 969,368 824,220 Lease liability 126,637 98,668 Other 51,764 20,154 Total deferred tax assets 4,632,952 4,178,196 Deferred tax liabilities: Right-of-use asset (111,777) (75,212) Investments (20,183) (30,962) Other (28,416) (17,309) Total deferred tax liabilities (160,376) (123,483) Total net deferred tax assets before valuation allowance 4,472,576 4,054,713 Valuation allowance (4,471,571) (4,060,943) Net deferred taxes $ 1,005 $ (6,230) |
Summary of Activity Related to Gross Unrecognized Tax Benefits | The following table summarizes the activity related to our gross unrecognized tax benefits for the years ended December 31, 2023, 2022, and 2021: Year Ended December 31, 2023 2022 2021 (in thousands) Beginning balance of unrecognized tax benefits $ 510,669 $ 469,573 $ 344,971 Additions for current year tax positions 46,188 47,366 119,938 Additions for prior year tax positions 10,171 115 180 Reductions for prior year tax positions (16,736) (3,569) (996) Changes due to lapse of statute of limitations (31,786) (1,887) (2,077) Reductions for settlements with taxing authorities (4,927) — — Changes due to foreign currency translation adjustments (175) (929) (357) U.K. corporate rate increase — — 7,914 Ending balance of unrecognized tax benefits (excluding interest and penalties) 513,404 510,669 469,573 Interest and penalties associated with unrecognized tax benefits 967 385 124 Ending balance of unrecognized tax benefits (including interest and penalties) $ 514,371 $ 511,054 $ 469,697 |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Income (Loss) (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Accumulated Other Comprehensive Income Loss [Abstract] | |
Schedule of Changes in Accumulated Other Comprehensive Income (Loss) | The table below presents the changes in accumulated other comprehensive income (loss) (“AOCI”) by component and the reclassifications out of AOCI: Changes in Accumulated Other Comprehensive Income (Loss) by Component Marketable Foreign Currency Total (in thousands) Balance at December 31, 2022 $ (11,129) $ (2,845) $ (13,974) OCI before reclassifications 8,643 12,836 21,479 Amounts reclassified from AOCI (1) (374) — (374) Net current period OCI 8,269 12,836 21,105 Balance at December 31, 2023 $ (2,860) $ 9,991 $ 7,131 (1) |
Property and Equipment, Net (Ta
Property and Equipment, Net (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Property, Plant and Equipment [Abstract] | |
Summary of Property and Equipment, Net | Property and equipment, net, consisted of the following: As of December 31, 2023 2022 (in thousands) Computer hardware and software $ 67,989 $ 62,945 Buildings 21,486 21,486 Leasehold improvements 332,721 225,647 Furniture and equipment 162,476 100,025 Construction in progress 90,038 80,267 Total 674,710 490,370 Less: accumulated depreciation and amortization (264,384) (218,593) Property and equipment, net $ 410,326 $ 271,777 |
Schedule of Property and Equipment, Net by Geographic Area | The following table lists property and equipment, net by geographic area: As of December 31, 2023 2022 (in thousands) United States $ 247,106 $ 214,857 United Kingdom 122,013 36,774 Rest of world (1) 41,207 20,146 Total property and equipment, net $ 410,326 $ 271,777 (1) No individual country exceeded 10% of our total property and equipment, net for any period presented. |
Balance Sheet Components (Table
Balance Sheet Components (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Schedule of Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities at December 31, 2023 and 2022 consisted of the following: As of December 31, 2023 2022 (in thousands) Accrued infrastructure costs $ 281,682 $ 169,886 Partner revenue share liabilities 99,877 83,395 Accrued compensation and related expenses 95,600 206,441 Deferred revenue (1) 93,706 50,782 Other operating costs 75,905 75,376 Acquisition liabilities 7,359 293,332 Other 151,707 108,128 Total accrued expenses and other current liabilities $ 805,836 $ 987,340 (1) We expect a substantial majority of our deferred revenue to be realized in less than one year. |
Restructuring (Tables)
Restructuring (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Restructuring and Related Activities [Abstract] | |
Schedule of Restructuring and Related Costs | The following table summarizes the restructuring charges (benefits) in our consolidated statements of operations for the year ended December 31, 2022: Severance and Related Charges (1) Stock-Based Compensation Expense (Benefit) Lease Exit and Related Charges (2) Other (3) Total (in thousands) Cost of revenue $ 2,291 $ 709 $ — $ 17,585 $ 20,585 Research and development 46,994 29,188 — 2,733 78,915 Sales and marketing 30,565 (504) — 730 30,791 General and administrative 17,211 5,111 31,227 5,109 58,658 Total $ 97,061 $ 34,504 $ 31,227 $ 26,157 $ 188,949 (1) Severance and related charges include cash severance expense and other termination benefits. The majority of cash paid for restructuring in 2022 was related to severance and benefits. (2) Lease exit and related charges are non-cash and presented in other cash flows from operating activities in our consolidated statements of cash flows. (3) Other includes impairment charges, contract termination charges, and intangible asset amortization. |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies - Additional Information (Details) | 1 Months Ended | 12 Months Ended | |||
Jun. 30, 2023 d $ / shares | Jul. 31, 2022 d $ / shares | Dec. 31, 2023 USD ($) vote reportingUnit segment | Dec. 31, 2022 USD ($) segment reportingUnit | Dec. 31, 2021 USD ($) reportingUnit segment | |
Summary Of Significant Accounting Policies [Line Items] | |||||
Cost, Product and Service [Extensible Enumeration] | Advertising [Member] | Advertising [Member] | Advertising [Member] | ||
Advertising partner arrangement cost | $ 675,000,000 | $ 681,900,000 | $ 679,000,000 | ||
Advertising cost | $ 24,900,000 | 42,700,000 | $ 62,400,000 | ||
Weighted average price per share (in usd per share) | $ / shares | $ 40 | $ 40 | |||
Common stock, convertible, threshold trading days | d | 90 | 65 | |||
Common stock, convertible, volume weighted average price per share (in usd per share) | $ / shares | $ 8.70 | ||||
Common stock, convertible, volume weighted average price per share, S&P 500 total return index (in usd per share) | $ / shares | $ 8,862.85 | ||||
Percentage of tax benefits likelihood of being realized | 0.50 | ||||
Maturity of time deposits | 90 days | ||||
Credit losses recorded on available-for-sale debt securities | $ 0 | $ 0 | |||
Number of operating segment | segment | 1 | 1 | 1 | ||
Number of reporting unit | reportingUnit | 1 | 1 | 1 | ||
Goodwill impairment charges | $ 0 | $ 0 | $ 0 | ||
Computer Hardware, Software and Equipment | |||||
Summary Of Significant Accounting Policies [Line Items] | |||||
Property and equipment estimated useful life | 3 years | ||||
Furniture and equipment | |||||
Summary Of Significant Accounting Policies [Line Items] | |||||
Property and equipment estimated useful life | 5 years | ||||
Minimum | Buildings | |||||
Summary Of Significant Accounting Policies [Line Items] | |||||
Property and equipment estimated useful life | 20 years | ||||
Minimum | RSUs and RSAs Granted after February 2018 | |||||
Summary Of Significant Accounting Policies [Line Items] | |||||
Service condition satisfied (in years) | 3 years | ||||
Maximum | Buildings | |||||
Summary Of Significant Accounting Policies [Line Items] | |||||
Property and equipment estimated useful life | 45 years | ||||
Maximum | RSUs and RSAs Granted after February 2018 | |||||
Summary Of Significant Accounting Policies [Line Items] | |||||
Service condition satisfied (in years) | 4 years | ||||
Class A Non-voting Common Stock | |||||
Summary Of Significant Accounting Policies [Line Items] | |||||
Stock split ratio, common stock | 1 | ||||
Class B | |||||
Summary Of Significant Accounting Policies [Line Items] | |||||
Number of votes per share | vote | 1 | ||||
Class C | |||||
Summary Of Significant Accounting Policies [Line Items] | |||||
Number of votes per share | vote | 10 |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Summary of Estimated Useful Lives of Intangible Assets (Details) | Dec. 31, 2023 |
Domain names | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated Useful Life | 5 years |
Trademarks | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated Useful Life | 3 years |
Acquired developed technology | Minimum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated Useful Life | 3 years |
Acquired developed technology | Maximum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated Useful Life | 7 years |
Customer relationships | Minimum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated Useful Life | 2 years |
Customer relationships | Maximum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated Useful Life | 8 years |
Patents | Minimum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated Useful Life | 4 years |
Patents | Maximum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated Useful Life | 14 years |
Revenue (Details)
Revenue (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disaggregation Of Revenue [Line Items] | |||
Total revenue | $ 4,606,115 | $ 4,601,847 | $ 4,117,048 |
North America | |||
Disaggregation Of Revenue [Line Items] | |||
Total revenue | 2,952,301 | 3,205,554 | 2,871,369 |
United States | |||
Disaggregation Of Revenue [Line Items] | |||
Total revenue | 2,900,000 | 3,100,000 | 2,800,000 |
Europe | |||
Disaggregation Of Revenue [Line Items] | |||
Total revenue | 772,078 | 712,764 | 660,473 |
Rest of world | |||
Disaggregation Of Revenue [Line Items] | |||
Total revenue | $ 881,736 | $ 683,529 | $ 585,206 |
Net Loss per Share - Additional
Net Loss per Share - Additional Information (Details) | Dec. 31, 2023 class |
Earnings Per Share [Abstract] | |
Number of classes of stock | 3 |
Net Loss per Share - Schedule o
Net Loss per Share - Schedule of Numerators and Denominators of Basic and Diluted Net Loss per Share Computations for Common Stock (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Numerator: | |||
Net loss | $ (1,322,485) | $ (1,429,653) | $ (487,955) |
Basic shares: | |||
Weighted-average common shares - Basic (in shares) | 1,612,504 | 1,608,304 | 1,558,997 |
Diluted shares: | |||
Weighted-average common shares - Diluted (in shares) | 1,612,504 | 1,608,304 | 1,558,997 |
Net loss per share attributable to common stockholders: | |||
Basic (in usd per share) | $ (0.82) | $ (0.89) | $ (0.31) |
Diluted (in usd per share) | $ (0.82) | $ (0.89) | $ (0.31) |
Class A | |||
Numerator: | |||
Net loss | $ (1,114,039) | $ (1,203,614) | $ (408,118) |
Net loss attributable to common stockholders | $ (1,114,039) | $ (1,203,614) | $ (408,118) |
Basic shares: | |||
Weighted-average common shares - Basic (in shares) | 1,358,345 | 1,354,019 | 1,303,921 |
Diluted shares: | |||
Weighted-average common shares - Diluted (in shares) | 1,358,345 | 1,354,019 | 1,303,921 |
Net loss per share attributable to common stockholders: | |||
Basic (in usd per share) | $ (0.82) | $ (0.89) | $ (0.31) |
Diluted (in usd per share) | $ (0.82) | $ (0.89) | $ (0.31) |
Class B | |||
Numerator: | |||
Net loss | $ (18,479) | $ (20,141) | $ (7,339) |
Net loss attributable to common stockholders | $ (18,479) | $ (20,141) | $ (7,339) |
Basic shares: | |||
Weighted-average common shares - Basic (in shares) | 22,532 | 22,658 | 23,449 |
Diluted shares: | |||
Weighted-average common shares - Diluted (in shares) | 22,532 | 22,658 | 23,449 |
Net loss per share attributable to common stockholders: | |||
Basic (in usd per share) | $ (0.82) | $ (0.89) | $ (0.31) |
Diluted (in usd per share) | $ (0.82) | $ (0.89) | $ (0.31) |
Class C | |||
Numerator: | |||
Net loss | $ (189,967) | $ (205,898) | $ (72,498) |
Net loss attributable to common stockholders | $ (189,967) | $ (205,898) | $ (72,498) |
Basic shares: | |||
Weighted-average common shares - Basic (in shares) | 231,627 | 231,627 | 231,627 |
Diluted shares: | |||
Weighted-average common shares - Diluted (in shares) | 231,627 | 231,627 | 231,627 |
Net loss per share attributable to common stockholders: | |||
Basic (in usd per share) | $ (0.82) | $ (0.89) | $ (0.31) |
Diluted (in usd per share) | $ (0.82) | $ (0.89) | $ (0.31) |
Net Loss per Share - Schedule_2
Net Loss per Share - Schedule of Potentially Dilutive Shares Excluded from Calculation of Diluted Net Loss per Share (Details) - shares shares in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Stock options | |||
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
Anti-dilutive securities excluded from calculation of diluted net loss per share (in shares) | 1,697 | 3,159 | 4,304 |
Unvested RSUs and RSAs | |||
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
Anti-dilutive securities excluded from calculation of diluted net loss per share (in shares) | 157,130 | 132,392 | 86,180 |
Convertible Notes (if-converted) | |||
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
Anti-dilutive securities excluded from calculation of diluted net loss per share (in shares) | 89,379 | 89,379 | 62,755 |
Stockholders' Equity - Addition
Stockholders' Equity - Additional Information (Details) $ / shares in Units, $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||
Dec. 31, 2023 USD ($) vote plan $ / shares shares | Dec. 31, 2022 USD ($) $ / shares shares | Dec. 31, 2023 USD ($) vote plan $ / shares shares | Dec. 31, 2022 USD ($) $ / shares shares | Dec. 31, 2021 USD ($) $ / shares shares | Oct. 31, 2023 USD ($) | Oct. 31, 2022 USD ($) | Sep. 30, 2022 USD ($) shares | Jul. 31, 2022 USD ($) | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Common stock, outstanding (in shares) | 1,694,696,000 | 1,625,398,000 | 1,694,696,000 | 1,625,398,000 | 1,619,283,000 | ||||
Number of share-based employee compensation plans | plan | 3 | 3 | |||||||
Weighted-average fair value of employee stock options (in usd per share) | $ / shares | $ 8.41 | $ 36.17 | |||||||
Fair values of options vested | $ | $ 1,100 | $ 3,200 | $ 7,700 | ||||||
Intrinsic values of stock options exercised | $ | $ 12,300 | $ 5,900 | 12,300 | 5,900 | 69,400 | ||||
Stock repurchased during period | $ | 479,903 | $ 500,514 | $ 479,903 | 500,514 | |||||
2017 Equity Incentive Plan | Maximum | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Percentage of capital stock outstanding | 5% | ||||||||
Stock options | Maximum | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Maximum term for stock options from the grant date | 10 years | ||||||||
Restricted Stock Units and Restricted Stock Awards | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Fair value of vested shares | $ | $ 1,000,000 | $ 1,200,000 | $ 3,600,000 | ||||||
Unrecognized compensation cost | $ | $ 1,700,000 | $ 1,700,000 | |||||||
Weighted average recognition period | 2 years | ||||||||
Class A | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Common stock, authorized (in shares) | 3,000,000,000 | 3,000,000,000 | 3,000,000,000 | 3,000,000,000 | |||||
Common stock, par value (in usd per share) | $ / shares | $ 0.00001 | $ 0.00001 | $ 0.00001 | $ 0.00001 | |||||
Common stock dividends declared (in usd per share) | $ / shares | $ 0 | ||||||||
Common stock, issued (in shares) | 1,440,540,591 | 1,371,242,000 | 1,440,540,591 | 1,371,242,000 | |||||
Common stock, outstanding (in shares) | 1,391,341,262 | 1,319,930,000 | 1,391,341,262 | 1,319,930,000 | |||||
Stock repurchase program, authorized amount | $ | $ 310,800 | $ 310,800 | $ 500,000 | $ 500,000 | $ 500,000 | ||||
Treasury stock, acquired (in shares) | 18,400,000 | ||||||||
Treasury stock, acquired | $ | $ 189,400 | ||||||||
Retirement of Class A non-voting common stock (in shares) | 53,900,000 | ||||||||
Stock repurchased and retired during period | $ | $ 500,500 | ||||||||
Stock repurchased during period (in shares) | 49,200,000 | 51,312,000 | 49,200,000 | 51,312,000 | 51,300,000 | ||||
Stock repurchased during period | $ | $ 500,500 | ||||||||
Class A | 2017 Equity Incentive Plan | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Common stock reserved for future issuance (in shares) | 87,270,108 | 87,270,108 | |||||||
Class A | 2017 Equity Incentive Plan | Maximum | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Additional common stock reserved for future issuance (in shares) | 86,737,997 | 86,737,997 | |||||||
Class A | 2014 Equity Incentive Plan | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Common stock reserved for future issuance (in shares) | 17,858,235 | 17,858,235 | |||||||
Class A | 2012 Equity Incentive Plan | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Common stock reserved for future issuance (in shares) | 11,004,580 | 11,004,580 | |||||||
Class A | 2017 Employee Stock Purchase Plan | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Common stock reserved for future issuance (in shares) | 16,484,690 | 16,484,690 | |||||||
Number of shares issued or offered under plan (in shares) | 0 | ||||||||
Percentage of number of shares, common stock outstanding | 1% | ||||||||
Class A | 2017 Employee Stock Purchase Plan | Maximum | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Increase in number of shares reserved for issuance (in shares) | 15,000,000 | ||||||||
Class A | Stock Options And Unvested RSUs | 2014 Equity Incentive Plan | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Common stock reserved for future issuance (in shares) | 96,993,064 | 96,993,064 | |||||||
Class A | Stock Options And Unvested RSUs | 2012 Equity Incentive Plan | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Common stock reserved for future issuance (in shares) | 37,228,865 | 37,228,865 | |||||||
Class A | Restricted Stock Units and Restricted Stock Awards | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Outstanding restricted stock, Granted (in shares) | 148,701,000 | ||||||||
Class A | France | 2014 Equity Incentive Plan | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Outstanding restricted stock, Granted (in shares) | 2,500,000 | ||||||||
Class B | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Common stock, authorized (in shares) | 700,000,000 | 700,000,000 | 700,000,000 | 700,000,000 | |||||
Common stock, par value (in usd per share) | $ / shares | $ 0.00001 | $ 0.00001 | $ 0.00001 | $ 0.00001 | |||||
Number of votes per share | vote | 1 | 1 | |||||||
Common stock dividends declared (in usd per share) | $ / shares | $ 0 | ||||||||
Common stock, issued (in shares) | 22,528,406 | 22,529,000 | 22,528,406 | 22,529,000 | |||||
Common stock, outstanding (in shares) | 22,528,406 | 22,529,000 | 22,528,406 | 22,529,000 | |||||
Class C | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Common stock, authorized (in shares) | 260,887,848 | 260,888,000 | 260,887,848 | 260,888,000 | |||||
Common stock, par value (in usd per share) | $ / shares | $ 0.00001 | $ 0.00001 | $ 0.00001 | $ 0.00001 | |||||
Number of votes per share | vote | 10 | 10 | |||||||
Common stock dividends declared (in usd per share) | $ / shares | $ 0 | ||||||||
Common stock, issued (in shares) | 231,626,943 | 231,627,000 | 231,626,943 | 231,627,000 | |||||
Common stock, outstanding (in shares) | 231,626,943 | 231,627,000 | 231,626,943 | 231,627,000 |
Stockholders' Equity - Summary
Stockholders' Equity - Summary of RSU and RSA Award Activity (Details) - Restricted Stock Units and Restricted Stock Awards - Class A shares in Thousands | 12 Months Ended |
Dec. 31, 2023 $ / shares shares | |
Class A Number of Shares | |
Outstanding restricted stock, unvested beginning balance (in shares) | shares | 132,392 |
Outstanding restricted stock, Granted (in shares) | shares | 148,701 |
Outstanding restricted stock, Vested (in shares) | shares | (91,641) |
Outstanding restricted stock, Forfeited (in shares) | shares | (32,322) |
Outstanding restricted stock, unvested ending balance (in shares) | shares | 157,130 |
Weighted- Average Grant Date Fair Value | |
Weighted-average grant date fair value per restricted stock, unvested beginning balance (in usd per share) | $ / shares | $ 18.28 |
Weighted-average grant date fair value per restricted stock, Granted (in usd per share) | $ / shares | 10.41 |
Weighted-average grant date fair value per restricted stock, Vested (in usd per share) | $ / shares | 15.71 |
Weighted-average grant date fair value per restricted stock, Forfeited (in usd per share) | $ / shares | 15.90 |
Weighted-average grant date fair value per restricted stock, unvested ending balance (in usd per share) | $ / shares | $ 12.82 |
Stockholders' Equity - Summar_2
Stockholders' Equity - Summary of Stock Option Award Activity (Details) - Stock options - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Weighted- Average Exercise Price | ||
Weighted-Average Exercise Price, Beginning balance (in usd per share) | $ 9.68 | |
Weighted-Average Exercise Price, Granted (in usd per share) | 0 | |
Weighted-Average Exercise Price, Exercised (in usd per share) | 0.89 | |
Weighted-Average Exercise Price, Forfeited (in usd per share) | 14.27 | |
Weighted-Average Exercise Price, Ending balance (in usd per share) | 14.90 | $ 9.68 |
Weighted-Average Exercise Price, Exercisable (in usd per share) | 14.90 | |
Weighted-Average Exercise Price, Vested and expected to vest (in usd per share) | $ 14.90 | |
Weighted- Average Remaining Contractual Term (in years) | ||
Weighted-Average Remaining Contractual Term | 4 years 4 months 28 days | 4 years 18 days |
Weighted-Average Remaining Contractual Term, Exercisable | 4 years 4 months 28 days | |
Weighted-Average Remaining Contractual Term, Vested and expected to vest | 4 years 4 months 28 days | |
Aggregate Intrinsic Value | ||
Aggregate Intrinsic Value, Outstanding | $ 5,225 | $ 9,669 |
Aggregate Intrinsic Value, Exercisable | 5,225 | |
Aggregate Intrinsic Value, Vested and expected to vest | $ 5,225 | |
Class A | ||
Number of Shares | ||
Beginning balance (in shares) | 2,589 | |
Granted (in shares) | 0 | |
Exercised (in shares) | (599) | |
Forfeited (in shares) | (298) | |
Ending balance (in shares) | 1,692 | 2,589 |
Exercisable (in shares) | 1,692 | |
Vested and expected to vest (in shares) | 1,692 | |
Class B | ||
Number of Shares | ||
Beginning balance (in shares) | 570 | |
Granted (in shares) | 0 | |
Exercised (in shares) | (565) | |
Forfeited (in shares) | 0 | |
Ending balance (in shares) | 5 | 570 |
Exercisable (in shares) | 5 | |
Vested and expected to vest (in shares) | 5 |
Stockholders' Equity - Summar_3
Stockholders' Equity - Summary of Total Stock-based Compensation Expense (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total | $ 1,324,004 | $ 1,387,787 | $ 1,092,135 |
Cost of revenue | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total | 9,555 | 12,288 | 17,221 |
Research and development | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total | 893,026 | 970,746 | 740,130 |
Sales and marketing | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total | 255,688 | 203,092 | 164,241 |
General and administrative | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total | $ 165,735 | $ 201,661 | $ 170,543 |
Business Acquisitions - Additio
Business Acquisitions - Additional Information (Details) - USD ($) $ in Thousands, shares in Millions | 1 Months Ended | 12 Months Ended | |||
May 31, 2021 | Mar. 31, 2021 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Business Acquisition [Line Items] | |||||
Goodwill | $ 1,691,827 | $ 1,646,120 | $ 1,588,452 | ||
2023 Acquisitions | |||||
Business Acquisition [Line Items] | |||||
Purchase price consideration | 73,100 | ||||
Payment to acquire business | 56,300 | ||||
Goodwill | 42,800 | ||||
2023 Acquisitions | Other Liabilities | |||||
Business Acquisition [Line Items] | |||||
Business combination, recognized identifiable assets acquired and liabilities assumed, liabilities | $ 12,600 | ||||
2022 Acquisitions | |||||
Business Acquisition [Line Items] | |||||
Purchase price consideration | 120,500 | ||||
Payment to acquire business | 17,700 | ||||
Goodwill | 69,300 | ||||
Goodwill deductible for tax purposes | 101,700 | ||||
2022 Acquisitions | Other Liabilities | |||||
Business Acquisition [Line Items] | |||||
Business combination, recognized identifiable assets acquired and liabilities assumed, liabilities | 58,800 | ||||
Wave Optics | |||||
Business Acquisition [Line Items] | |||||
Purchase price consideration | $ 510,400 | ||||
Payment to acquire business | 13,700 | ||||
Business combination, recognized identifiable assets acquired and liabilities assumed, liabilities | 238,400 | ||||
Goodwill | 370,236 | ||||
Business combination, consideration transferred, equity interests issued and issuable | 252,000 | ||||
Business combination total consideration including post combination expense | 541,800 | ||||
Business combination, post combination expense | $ 31,400 | ||||
Fit Analytics | |||||
Business Acquisition [Line Items] | |||||
Purchase price consideration | $ 124,400 | ||||
Goodwill | $ 88,132 | ||||
Other Acquisitions | |||||
Business Acquisition [Line Items] | |||||
Payment to acquire business | 139,500 | ||||
Business combination, recognized identifiable assets acquired and liabilities assumed, liabilities | 32,900 | ||||
Goodwill | 203,482 | ||||
Business combination, consideration transferred, equity interests issued and issuable | 93,700 | ||||
Goodwill deductible for tax purposes | 8,200 | ||||
Business combination total consideration including post combination expense | $ 266,100 | ||||
Class A Common Stock | 2022 Acquisitions | |||||
Business Acquisition [Line Items] | |||||
Business combination, consideration transferred, equity interests issued and issuable | $ 44,000 | ||||
Class A Common Stock | Wave Optics | |||||
Business Acquisition [Line Items] | |||||
Business combination consideration in shares issued or issuable (in shares) | 4.7 |
Business Acquisitions - Summary
Business Acquisitions - Summary of Total Purchase Consideration Allocation (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | May 31, 2021 | Mar. 31, 2021 |
Business Acquisition [Line Items] | |||||
Goodwill | $ 1,691,827 | $ 1,646,120 | $ 1,588,452 | ||
Wave Optics | |||||
Business Acquisition [Line Items] | |||||
Goodwill | $ 370,236 | ||||
Net deferred tax liability | (3,313) | ||||
Other assets acquired and liabilities assumed, net | 13,111 | ||||
Total | 510,444 | ||||
Wave Optics | Trademarks | |||||
Business Acquisition [Line Items] | |||||
Finite lived intangible assets | 20,584 | ||||
Wave Optics | Technology | |||||
Business Acquisition [Line Items] | |||||
Finite lived intangible assets | 77,118 | ||||
Wave Optics | Customer relationships | |||||
Business Acquisition [Line Items] | |||||
Finite lived intangible assets | $ 32,708 | ||||
Fit Analytics | |||||
Business Acquisition [Line Items] | |||||
Goodwill | $ 88,132 | ||||
Net deferred tax liability | (5,643) | ||||
Other assets acquired and liabilities assumed, net | 7,160 | ||||
Total | 124,449 | ||||
Fit Analytics | Trademarks | |||||
Business Acquisition [Line Items] | |||||
Finite lived intangible assets | 800 | ||||
Fit Analytics | Technology | |||||
Business Acquisition [Line Items] | |||||
Finite lived intangible assets | 17,000 | ||||
Fit Analytics | Customer relationships | |||||
Business Acquisition [Line Items] | |||||
Finite lived intangible assets | $ 17,000 | ||||
Other Acquisitions | |||||
Business Acquisition [Line Items] | |||||
Goodwill | 203,482 | ||||
Net deferred tax liability | (11,871) | ||||
Other assets acquired and liabilities assumed, net | 6,325 | ||||
Total | 266,086 | ||||
Other Acquisitions | Technology | |||||
Business Acquisition [Line Items] | |||||
Finite lived intangible assets | 64,150 | ||||
Other Acquisitions | Customer relationships | |||||
Business Acquisition [Line Items] | |||||
Finite lived intangible assets | $ 4,000 |
Goodwill and Intangible Asset_2
Goodwill and Intangible Assets - Schedule of Changes in Carrying Amount of Goodwill (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Goodwill [Roll Forward] | ||
Goodwill, beginning balance | $ 1,646,120 | $ 1,588,452 |
Goodwill acquired | 42,780 | 69,291 |
Foreign currency translation | 2,927 | (11,623) |
Goodwill, ending balance | $ 1,691,827 | $ 1,646,120 |
Goodwill and Intangible Asset_3
Goodwill and Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | $ 369,431 | $ 408,502 |
Accumulated Amortization | (223,128) | (204,022) |
Net | $ 146,303 | $ 204,480 |
Domain names | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted- Average Remaining Useful Life - Years | 3 years | 4 years |
Gross Carrying Amount | $ 745 | $ 954 |
Accumulated Amortization | (546) | (690) |
Net | $ 199 | $ 264 |
Trademarks | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted- Average Remaining Useful Life - Years | 1 year 2 months 12 days | |
Gross Carrying Amount | $ 800 | |
Accumulated Amortization | (478) | |
Net | $ 322 | |
Technology | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted- Average Remaining Useful Life - Years | 2 years 9 months 18 days | 3 years 1 month 6 days |
Gross Carrying Amount | $ 323,313 | $ 340,375 |
Accumulated Amortization | (197,608) | (178,427) |
Net | $ 125,705 | $ 161,948 |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted- Average Remaining Useful Life - Years | 5 years 8 months 12 days | |
Gross Carrying Amount | $ 21,000 | |
Accumulated Amortization | (6,641) | |
Net | $ 14,359 | |
Patents | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted- Average Remaining Useful Life - Years | 8 years 9 months 18 days | 9 years 1 month 6 days |
Gross Carrying Amount | $ 39,373 | $ 39,373 |
Accumulated Amortization | (19,099) | (14,912) |
Net | 20,274 | $ 24,461 |
Other | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted- Average Remaining Useful Life - Years | 1 year | |
Gross Carrying Amount | 6,000 | $ 6,000 |
Accumulated Amortization | (5,875) | (2,874) |
Net | $ 125 | $ 3,126 |
Goodwill and Intangible Asset_4
Goodwill and Intangible Assets - Additional Information (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Finite-Lived Intangible Assets [Line Items] | |||
Amortization of intangible assets | $ 81.1 | $ 132.3 | $ 63.2 |
Customer Relationships, Trademarks, Domain Names, and Technology | |||
Finite-Lived Intangible Assets [Line Items] | |||
Increase in amortization of intangible assets | $ 19.9 | $ 49.3 |
Goodwill and Intangible Asset_5
Goodwill and Intangible Assets - Schedule of Estimated Intangible Asset Amortization Expense (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
2024 | $ 58,532 | |
2025 | 42,513 | |
2026 | 20,776 | |
2027 | 12,104 | |
2028 | 4,323 | |
Thereafter | 8,055 | |
Net | $ 146,303 | $ 204,480 |
Long-Term Debt - Additional Inf
Long-Term Debt - Additional Information (Details) - USD ($) | 1 Months Ended | 12 Months Ended | ||||||
May 31, 2022 | Feb. 28, 2022 | Apr. 30, 2021 | Apr. 30, 2020 | Aug. 31, 2019 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Debt Instrument [Line Items] | ||||||||
Debt instrument, principal amount | $ 3,772,587,000 | $ 3,772,587,000 | ||||||
Proceeds from issuance of convertible notes, net of issuance costs | 0 | 1,483,500,000 | $ 1,137,227,000 | |||||
Induced conversion expense related to convertible notes | 0 | 0 | 41,538,000 | |||||
Amortization of debt issuance costs | 7,361,000 | 6,865,000 | 4,311,000 | |||||
Senior Unsecured Revolving Credit Facility | ||||||||
Debt Instrument [Line Items] | ||||||||
Line of credit facility, expiration period | 5 years | |||||||
Maximum borrowing capacity | $ 1,050,000,000 | |||||||
Annual commitment fee | 0.10% | |||||||
Outstanding letters of credit | 49,600,000 | |||||||
Amounts outstanding under the credit facility | 0 | |||||||
Senior Unsecured Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | ||||||||
Debt Instrument [Line Items] | ||||||||
Basis spread on variable interest rate (percentage) | 0.75% | |||||||
Senior Unsecured Revolving Credit Facility | Sterling Overnight Index | ||||||||
Debt Instrument [Line Items] | ||||||||
Basis spread on variable interest rate (percentage) | 0.7826% | |||||||
Senior Unsecured Revolving Credit Facility | Miscellaneous | ||||||||
Debt Instrument [Line Items] | ||||||||
Basis spread on variable interest rate (percentage) | 0.75% | |||||||
Senior Unsecured Revolving Credit Facility | Fed Funds Effective Rate Overnight Index Swap Rate | ||||||||
Debt Instrument [Line Items] | ||||||||
Basis spread on variable interest rate (percentage) | 0.50% | |||||||
Senior Unsecured Revolving Credit Facility | One Month Secured Overnight Financing Rate S O F R Overnight Index Swap Rate | ||||||||
Debt Instrument [Line Items] | ||||||||
Line of credit facility, expiration period | 1 month | |||||||
Basis spread on variable interest rate (percentage) | 100% | |||||||
Exchange Agreements | ||||||||
Debt Instrument [Line Items] | ||||||||
Induced conversion expense related to convertible notes | 41,500,000 | |||||||
Issuance of Class A non-voting common stock for the induced conversion related to convertible senior notes | $ 1,132,600,000 | |||||||
Class A Non-voting Common Stock | Exchange Agreements | ||||||||
Debt Instrument [Line Items] | ||||||||
Shares issued upon conversion of each $1000 principal amount (in shares) | 52,400,000 | |||||||
Additional shares issued upon conversion (in shares) | 700,000 | |||||||
Issuance of Class A non-voting common stock for the induced conversion related to convertible senior notes (in shares) | 700,000 | |||||||
2028 Notes | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, principal amount | $ 1,500,000,000 | $ 1,500,000,000 | 1,500,000,000 | |||||
Proceeds from debt net of issuance costs and capped call transaction costs | $ 1,310,000,000 | |||||||
Debt instrument, interest rate | 0.125% | |||||||
Debt instrument convertible, amortization period | 4 years 2 months 12 days | |||||||
Cap price, net cost | $ 177,000,000 | |||||||
2028 Notes | Class A Non-voting Common Stock | ||||||||
Debt Instrument [Line Items] | ||||||||
Shares issued upon conversion of each $1000 principal amount (in shares) | 17.7494 | |||||||
Debt instrument, convertible principal amount used in conversion rate | $ 1,000 | |||||||
Conversion price per share (in usd per share) | $ 56.34 | |||||||
Cap price, per share (in usd per share) | $ 93.90 | |||||||
2027 Notes | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, principal amount | $ 1,150,000,000 | $ 1,150,000,000 | 1,150,000,000 | |||||
Proceeds from issuance of convertible notes, net of issuance costs | $ 1,050,000,000 | |||||||
Debt instrument convertible, amortization period | 3 years 3 months 18 days | |||||||
Cap price, net cost | $ 86,800,000 | |||||||
2027 Notes | Class A Non-voting Common Stock | ||||||||
Debt Instrument [Line Items] | ||||||||
Shares issued upon conversion of each $1000 principal amount (in shares) | 11.2042 | |||||||
Debt instrument, convertible principal amount used in conversion rate | $ 1,000 | |||||||
Conversion price per share (in usd per share) | $ 89.25 | |||||||
Cap price, per share (in usd per share) | $ 121.02 | |||||||
2025 Notes | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, principal amount | $ 1,000,000,000 | $ 284,105,000 | 284,105,000 | |||||
Debt instrument, interest rate | 0.25% | |||||||
Debt issuance costs | $ 888,600,000 | |||||||
Debt instrument convertible, amortization period | 1 year 3 months 18 days | |||||||
Cap price, net cost | $ 100,000,000 | |||||||
2025 Notes | Exchange Agreements | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt conversion, principal amount | $ 715,900,000 | |||||||
2025 Notes | Class A Non-voting Common Stock | ||||||||
Debt Instrument [Line Items] | ||||||||
Shares issued upon conversion of each $1000 principal amount (in shares) | 46.1233 | |||||||
Debt instrument, convertible principal amount used in conversion rate | $ 1,000 | |||||||
Conversion price per share (in usd per share) | $ 21.68 | |||||||
Cap price, per share (in usd per share) | $ 32.12 | |||||||
2026 Notes | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, principal amount | $ 1,265,000,000 | $ 838,482,000 | 838,482,000 | |||||
Debt instrument, interest rate | 0.75% | |||||||
Proceeds from issuance of convertible notes, net of issuance costs | $ 1,150,000,000 | |||||||
Debt instrument convertible, amortization period | 2 years 7 months 6 days | |||||||
Cap price, net cost | $ 102,100,000 | |||||||
2026 Notes | Exchange Agreements | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt conversion, principal amount | 426,500,000 | |||||||
2026 Notes | Class A Non-voting Common Stock | ||||||||
Debt Instrument [Line Items] | ||||||||
Shares issued upon conversion of each $1000 principal amount (in shares) | 43.8481 | |||||||
Debt instrument, convertible principal amount used in conversion rate | $ 1,000 | |||||||
Conversion price per share (in usd per share) | $ 22.81 | |||||||
Cap price, per share (in usd per share) | $ 32.58 | |||||||
Convertible Notes | ||||||||
Debt Instrument [Line Items] | ||||||||
Amortization of debt issuance costs | $ 6,900,000 | 6,500,000 | 4,300,000 | |||||
Contractual interest expense | $ 8,900,000 | $ 8,700,000 | $ 8,900,000 |
Long-Term Debt - Summary of Con
Long-Term Debt - Summary of Convertible Notes (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 | Feb. 28, 2022 | Apr. 30, 2021 | Apr. 30, 2020 | Aug. 31, 2019 |
Debt Instrument [Line Items] | ||||||
Principal | $ 3,772,587 | $ 3,772,587 | ||||
Unamortized Debt Issuance Costs | (23,187) | (30,067) | ||||
Net Carrying Amount | 3,749,400 | 3,742,520 | ||||
2025 Notes | ||||||
Debt Instrument [Line Items] | ||||||
Principal | 284,105 | 284,105 | $ 1,000,000 | |||
Unamortized Debt Issuance Costs | (871) | (1,521) | ||||
Net Carrying Amount | 283,234 | 282,584 | ||||
2026 Notes | ||||||
Debt Instrument [Line Items] | ||||||
Principal | 838,482 | 838,482 | $ 1,265,000 | |||
Unamortized Debt Issuance Costs | (3,402) | (4,698) | ||||
Net Carrying Amount | 835,080 | 833,784 | ||||
2027 Notes | ||||||
Debt Instrument [Line Items] | ||||||
Principal | 1,150,000 | 1,150,000 | $ 1,150,000 | |||
Unamortized Debt Issuance Costs | (7,114) | (9,239) | ||||
Net Carrying Amount | 1,142,886 | 1,140,761 | ||||
2028 Notes | ||||||
Debt Instrument [Line Items] | ||||||
Principal | 1,500,000 | 1,500,000 | $ 1,500,000 | |||
Unamortized Debt Issuance Costs | (11,800) | (14,609) | ||||
Net Carrying Amount | $ 1,488,200 | $ 1,485,391 |
Commitments and Contingencies (
Commitments and Contingencies (Details) | 12 Months Ended |
Dec. 31, 2023 USD ($) | |
Loss Contingencies [Line Items] | |
Commitments due | $ 3,000,000,000 |
Contractual obligation maturity | 3 years |
Indemnification Agreement | |
Loss Contingencies [Line Items] | |
Liabilities recorded | $ 0 |
Leases - Additional Information
Leases - Additional Information (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Lessee Lease Description [Line Items] | |||
Operating lease cost | $ 101,000 | $ 109,500 | $ 69,800 |
Lease obligations for additional leases not yet commenced | 70,700 | ||
Operating cash outflows for operating leases | 97,700 | 94,900 | 73,900 |
Lease liabilities arising from obtaining operating lease right-of-use assets | $ 220,200 | $ 147,400 | $ 99,300 |
Minimum | |||
Lessee Lease Description [Line Items] | |||
Operating leases, terms | 7 years | ||
Maximum | |||
Lessee Lease Description [Line Items] | |||
Operating leases, terms | 11 years |
Leases - Summary of Weighted-av
Leases - Summary of Weighted-average Remaining Lease Term and Discount Rate Related to Operating Leases (Details) | Dec. 31, 2023 | Dec. 31, 2022 |
Leases [Abstract] | ||
Weighted-average remaining lease term | 10 years | 6 years 9 months 18 days |
Weighted-average discount rate | 6.10% | 5% |
Leases - Schedule of Present Va
Leases - Schedule of Present Value of Operating Lease Liabilities (Details) $ in Thousands | Dec. 31, 2023 USD ($) |
Leases [Abstract] | |
2024 | $ 86,440 |
2025 | 72,225 |
2026 | 84,100 |
2027 | 75,521 |
2028 | 72,890 |
Thereafter | 432,152 |
Total lease payments | 823,328 |
Less: Imputed interest | (227,728) |
Present value of lease liabilities | $ 595,600 |
Strategic Investments - Summary
Strategic Investments - Summary of Strategic Investments (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Equity Method Investments and Joint Ventures [Abstract] | ||
Initial cost | $ 106,368 | $ 125,564 |
Cumulative upward adjustments | 147,317 | 157,186 |
Cumulative downward adjustments, including impairments | (58,357) | (30,411) |
Carrying value | $ 195,328 | $ 252,339 |
Strategic Investments - Summa_2
Strategic Investments - Summary of Gain (Loss) on Strategic Investments (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Equity Method Investments and Joint Ventures [Abstract] | |||
Gains (losses) recognized on strategic investments sold during the period, net | $ 0 | $ 45,935 | $ 27,820 |
Unrealized gains on strategic investments still held at the reporting date | 1,368 | 19,946 | 145,010 |
Unrealized losses, including impairments, on strategic investments still held at the reporting date | (28,423) | (1,421) | (2,854) |
Gains (losses) on strategic investments, net | $ (27,055) | $ 64,460 | $ 169,976 |
Fair Value Measurements - Summa
Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Marketable securities, Total Estimated Fair Value | $ 1,800,000 | |
Fair Value, Measurements, Recurring | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Cash, Equity Securities and Marketable securities, Cost or Amortized Cost | 3,533,181 | $ 3,889,935 |
Equity Securities and Marketable securities, Gross Unrealized Gains | 1,502 | 160 |
Equity Securities and Marketable securities, Gross Unrealized Losses | (4,206) | (11,135) |
Cash, Equity Securities and Marketable Securities, Total Estimated Fair Value | 3,530,477 | 3,878,960 |
Fair Value, Measurements, Recurring | Cash | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Cash, Cost or Amortized Cost | 1,780,402 | 1,325,946 |
Cash, Total Estimated Fair Value | 1,780,402 | 1,325,946 |
Fair Value, Measurements, Recurring | Level 1 securities: | U.S. government securities | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Marketable securities, Cost or Amortized Cost | 1,295,918 | 1,630,224 |
Marketable securities, Gross Unrealized Gains | 894 | 109 |
Marketable securities, Gross Unrealized Losses | (3,919) | (9,484) |
Marketable securities, Total Estimated Fair Value | 1,292,893 | 1,620,849 |
Fair Value, Measurements, Recurring | Level 1 securities: | U.S. government agency securities | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Marketable securities, Cost or Amortized Cost | 138,420 | 175,269 |
Marketable securities, Gross Unrealized Gains | 31 | 19 |
Marketable securities, Gross Unrealized Losses | (188) | (188) |
Marketable securities, Total Estimated Fair Value | 138,263 | 175,100 |
Fair Value, Measurements, Recurring | Level 2 securities: | Corporate debt securities | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Marketable securities, Cost or Amortized Cost | 234,336 | 309,942 |
Marketable securities, Gross Unrealized Gains | 577 | 32 |
Marketable securities, Gross Unrealized Losses | (99) | (1,462) |
Marketable securities, Total Estimated Fair Value | 234,814 | 308,512 |
Fair Value, Measurements, Recurring | Level 2 securities: | Commercial paper | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Marketable securities, Cost or Amortized Cost | 65,380 | 290,589 |
Marketable securities, Gross Unrealized Gains | 0 | 0 |
Marketable securities, Gross Unrealized Losses | 0 | 0 |
Marketable securities, Total Estimated Fair Value | 65,380 | 290,589 |
Fair Value, Measurements, Recurring | Level 2 securities: | Certificates of deposit | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Marketable securities, Cost or Amortized Cost | 18,725 | 157,965 |
Marketable securities, Gross Unrealized Gains | 0 | 0 |
Marketable securities, Gross Unrealized Losses | 0 | (1) |
Marketable securities, Total Estimated Fair Value | $ 18,725 | $ 157,964 |
Fair Value Measurements - Addit
Fair Value Measurements - Additional Information (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Marketable securities contractual maturities | $ 760.2 | |
Marketable securities, total estimated fair value | 1,800 | |
Equity securities, cost or amortized cost | 13.6 | $ 91.5 |
2025 Notes | Level 2 securities: | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Convertible notes | 300.9 | 257 |
2026 Notes | Level 2 securities: | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Convertible notes | 893.2 | 711.9 |
2027 Notes | Level 2 securities: | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Convertible notes | 921.5 | 796.2 |
2028 Notes | Level 2 securities: | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Convertible notes | $ 1,181.7 | $ 1,000 |
Minimum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Marketable securities contractual maturities period | 1 year | |
Maximum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Marketable securities contractual maturities period | 5 years |
Fair Value Measurements - Sum_2
Fair Value Measurements - Summary of Gain (Loss) on Securities (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Fair Value Disclosures [Abstract] | |||
Gains (losses) recognized on publicly traded equity securities sold during the period, net | $ 11,046 | $ (22,095) | $ 0 |
Unrealized gains (losses) on publicly traded equity securities still held at the reporting date, net | (17,731) | (79,214) | 122,064 |
Gains (losses) on publicly traded equity securities, net | $ (6,685) | $ (101,309) | $ 122,064 |
Income Taxes - Schedule of Dome
Income Taxes - Schedule of Domestic and Foreign Components of Pre-Tax Loss (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |||
Domestic | $ (285,330) | $ (538,311) | $ 364,989 |
Foreign | (1,009,093) | (862,386) | (839,360) |
Loss before income taxes | $ (1,294,423) | $ (1,400,697) | $ (474,371) |
Income Taxes - Schedule of Comp
Income Taxes - Schedule of Components of Income Tax (Benefit) Expense (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Current: | |||
Federal | $ 0 | $ 0 | $ 0 |
State | 8,585 | 10,704 | 919 |
Foreign | 26,727 | 22,404 | 22,078 |
Total current income tax expense (benefit) | 35,312 | 33,108 | 22,997 |
Deferred: | |||
Federal | 1,267 | 1,212 | (6,295) |
State | 1,061 | 837 | (445) |
Foreign | (9,578) | (6,201) | (2,673) |
Total deferred income tax expense (benefit) | (7,250) | (4,152) | (9,413) |
Income tax expense (benefit) | $ 28,062 | $ 28,956 | $ 13,584 |
Income Taxes - Summary of Recon
Income Taxes - Summary of Reconciliation of Statutory Federal Income Tax Rate (Details) | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |||
Tax benefit (expense) computed at the federal statutory rate | 21% | 21% | 21% |
State tax benefit (expense), net of federal benefit | 2.20% | 2.90% | 31.50% |
Change in valuation allowance | (31.50%) | (32.00%) | (246.30%) |
Differences between U.S. and foreign tax rates on foreign income | 3.30% | 2.50% | 3.90% |
Stock-based compensation | (7.00%) | (0.10%) | 119.30% |
U.S. federal research & development credit benefit | 8.60% | 5% | 36.70% |
U.K. corporate rate increase | 0% | 0% | 39.80% |
Acquisitions and divestitures | 1.80% | (0.70%) | (8.00%) |
Other benefits (expenses) | (0.60%) | (0.70%) | (0.80%) |
Total income tax benefit (expense) | (2.20%) | (2.10%) | (2.90%) |
Income Taxes - Summary of Signi
Income Taxes - Summary of Significant Components of Net Deferred Tax Balances (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Deferred tax assets: | ||
Accruals and reserves | $ 22,475 | $ 37,731 |
Intangible assets | 168,661 | 177,762 |
IRC 174 capitalized R&D | 449,253 | 265,485 |
Stock-based compensation | 70,563 | 102,364 |
Loss carryforwards | 2,774,231 | 2,651,812 |
Tax credit carryforwards | 969,368 | 824,220 |
Lease liability | 126,637 | 98,668 |
Other | 51,764 | 20,154 |
Total deferred tax assets | 4,632,952 | 4,178,196 |
Deferred tax liabilities: | ||
Right-of-use asset | (111,777) | (75,212) |
Investments | (20,183) | (30,962) |
Other | (28,416) | (17,309) |
Total deferred tax liabilities | (160,376) | (123,483) |
Total net deferred tax assets before valuation allowance | 4,472,576 | 4,054,713 |
Valuation allowance | (4,471,571) | (4,060,943) |
Total net deferred tax assets before valuation allowance | $ 1,005 | $ 6,230 |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) - USD ($) $ in Thousands | 12 Months Ended | ||||||
Jun. 10, 2021 | Jun. 09, 2021 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2017 | Dec. 31, 2020 | |
Income Taxes [Line Items] | |||||||
Tax benefit (expense) computed at the federal statutory rate | 21% | 21% | 21% | ||||
Change in enacted tax rate, amount | $ 188,900 | ||||||
Deferred tax assets, valuation allowance | $ 4,471,571 | $ 4,060,943 | |||||
Unrecognized tax benefits | 513,404 | 510,669 | $ 469,573 | $ 344,971 | |||
Other Liabilities | |||||||
Income Taxes [Line Items] | |||||||
Unrecognized tax benefits | 27,300 | $ 21,700 | |||||
U.K. | |||||||
Income Taxes [Line Items] | |||||||
Tax benefit (expense) computed at the federal statutory rate | 25% | 19% | |||||
Net operating loss carry-forwards | $ 4,500,000 | ||||||
Percentage of taxable income limitation | 50% | ||||||
Federal | |||||||
Income Taxes [Line Items] | |||||||
Net operating loss carry-forwards | $ 6,700,000 | ||||||
Pre-tax act operating loss carry-forwards | $ 500,000 | ||||||
Pre-tax act operating loss carry-forwards period | 20 years | ||||||
Post-tax act operating loss carry-forwards | $ 6,200,000 | ||||||
Percentage of taxable income limitation | 80% | ||||||
Federal | Research | |||||||
Income Taxes [Line Items] | |||||||
Accumulated research tax credits | $ 816,600 | ||||||
State | |||||||
Income Taxes [Line Items] | |||||||
Net operating loss carry-forwards | 4,500,000 | ||||||
State | Research | |||||||
Income Taxes [Line Items] | |||||||
Accumulated research tax credits | $ 478,900 |
Income Taxes - Summary of Activ
Income Taxes - Summary of Activity Related to Gross Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | |||
Beginning balance of unrecognized tax benefits | $ 510,669 | $ 469,573 | $ 344,971 |
Additions for current year tax positions | 46,188 | 47,366 | 119,938 |
Additions for prior year tax positions | 10,171 | 115 | 180 |
Reductions for prior year tax positions | (16,736) | (3,569) | (996) |
Changes due to lapse of statute of limitations | (31,786) | (1,887) | (2,077) |
Reductions for settlements with taxing authorities | (4,927) | 0 | 0 |
Changes due to foreign currency translation adjustments | (175) | (929) | (357) |
U.K. corporate rate increase | 0 | 0 | 7,914 |
Ending balance of unrecognized tax benefits (excluding interest and penalties) | 513,404 | 510,669 | 469,573 |
Interest and penalties associated with unrecognized tax benefits | 967 | 385 | 124 |
Ending balance of unrecognized tax benefits (including interest and penalties) | $ 514,371 | $ 511,054 | $ 469,697 |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | |||
Balance, beginning of period | $ 2,580,698 | $ 3,790,168 | |
OCI before reclassifications | 21,479 | ||
Amounts reclassified from AOCI | (374) | ||
Total other comprehensive income (loss), net of tax | 21,105 | (19,495) | $ (15,842) |
Balance, end of period | 2,414,112 | 2,580,698 | 3,790,168 |
Accumulated other comprehensive income (loss) | |||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | |||
Balance, beginning of period | (13,974) | 5,521 | 21,363 |
Total other comprehensive income (loss), net of tax | 21,105 | (19,495) | (15,842) |
Balance, end of period | 7,131 | (13,974) | $ 5,521 |
Marketable Securities | |||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | |||
Balance, beginning of period | (11,129) | ||
OCI before reclassifications | 8,643 | ||
Amounts reclassified from AOCI | (374) | ||
Total other comprehensive income (loss), net of tax | 8,269 | ||
Balance, end of period | (2,860) | (11,129) | |
Foreign Currency Translation | |||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | |||
Balance, beginning of period | (2,845) | ||
OCI before reclassifications | 12,836 | ||
Amounts reclassified from AOCI | 0 | ||
Total other comprehensive income (loss), net of tax | 12,836 | ||
Balance, end of period | $ 9,991 | $ (2,845) |
Property and Equipment, Net - S
Property and Equipment, Net - Summary of Property and Equipment, Net (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Property Plant And Equipment [Line Items] | ||
Property and equipment, gross | $ 674,710 | $ 490,370 |
Less: accumulated depreciation and amortization | (264,384) | (218,593) |
Property and equipment, net | 410,326 | 271,777 |
Computer hardware and software | ||
Property Plant And Equipment [Line Items] | ||
Property and equipment, gross | 67,989 | 62,945 |
Buildings | ||
Property Plant And Equipment [Line Items] | ||
Property and equipment, gross | 21,486 | 21,486 |
Leasehold improvements | ||
Property Plant And Equipment [Line Items] | ||
Property and equipment, gross | 332,721 | 225,647 |
Furniture and equipment | ||
Property Plant And Equipment [Line Items] | ||
Property and equipment, gross | 162,476 | 100,025 |
Construction in progress | ||
Property Plant And Equipment [Line Items] | ||
Property and equipment, gross | $ 90,038 | $ 80,267 |
Property and Equipment, Net - A
Property and Equipment, Net - Additional Information (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Property Plant And Equipment [Line Items] | |||
Depreciation and amortization | $ 168,441 | $ 202,173 | $ 119,141 |
Capital expenditures incurred but not yet paid | 44,500 | 28,000 | 14,200 |
Property and Equipment | |||
Property Plant And Equipment [Line Items] | |||
Depreciation and amortization | $ 87,300 | $ 69,900 | $ 55,900 |
Property and Equipment, Net -_2
Property and Equipment, Net - Schedule of Property and Equipment, Net by Geographic Area (Details) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 USD ($) country | Dec. 31, 2022 USD ($) country | |
Property and equipment, net | ||
Total property and equipment, net | $ 410,326 | $ 271,777 |
United States | ||
Property and equipment, net | ||
Total property and equipment, net | 247,106 | 214,857 |
United Kingdom | ||
Property and equipment, net | ||
Total property and equipment, net | 122,013 | 36,774 |
Rest of world | ||
Property and equipment, net | ||
Total property and equipment, net | $ 41,207 | $ 20,146 |
Rest of world | Property and Equipment Net | Geographic Concentrations | ||
Property and equipment, net | ||
Number of individual country exceeded 10% of total property and equipment | country | 0 | 0 |
Balance Sheet Components (Detai
Balance Sheet Components (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Accrued infrastructure costs | $ 281,682 | $ 169,886 |
Partner revenue share liabilities | 99,877 | 83,395 |
Accrued compensation and related expenses | 95,600 | 206,441 |
Deferred revenue | 93,706 | 50,782 |
Other operating costs | 75,905 | 75,376 |
Acquisition liabilities | 7,359 | 293,332 |
Other | 151,707 | 108,128 |
Total accrued expenses and other current liabilities | $ 805,836 | $ 987,340 |
Employee Benefit Plans (Details
Employee Benefit Plans (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Defined Benefit Plan Disclosure [Line Items] | |||
Benefit plan, maximum eligible contributions per employee, percent | 100% | ||
Expense recognized related to matching contributions | $ 34 | $ 33.6 | $ 25 |
100% Participants Contribution | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Benefit plan, employer matching contribution percentage | 100% | ||
100% Participants Contribution | Maximum | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Benefit plan, employer matching contribution, percent of employees' base salary | 3% | ||
50% Participants Contribution | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Benefit plan, employer matching contribution percentage | 50% | ||
50% Participants Contribution | Maximum | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Benefit plan, employer matching contribution, percent of employees' base salary | 5% | ||
50% Participants Contribution | Minimum | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Benefit plan, employer matching contribution, percent of employees' base salary | 3% |
Related Party Transactions (Det
Related Party Transactions (Details) - Entity Controlled by CEO | 1 Months Ended |
Nov. 30, 2020 USD ($) | |
Related Party Transaction [Line Items] | |
Sublease payment amount | $ 0 |
Sublease term | 6 years |
Sublease termination option, written notice term | 24 months |
Restructuring - Additional Info
Restructuring - Additional Information (Details) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Restructuring and Related Activities [Abstract] | ||||
Percentage of employee reduction in reprioritization plan | 3% | 20% | ||
Restructuring charges | $ 40,800,000 | $ 188,949,000 | ||
Restructuring reserve | $ 0 | $ 0 |
Restructuring - Schedule of Res
Restructuring - Schedule of Restructuring and Related Costs (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | $ 40,800 | $ 188,949 |
Severance and Related Charges | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 97,061 | |
Stock-Based Compensation Expense (Benefit) | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 34,504 | |
Lease Exit and Related Charges | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 31,227 | |
Other | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 26,157 | |
Cost of revenue | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 20,585 | |
Cost of revenue | Severance and Related Charges | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 2,291 | |
Cost of revenue | Stock-Based Compensation Expense (Benefit) | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 709 | |
Cost of revenue | Lease Exit and Related Charges | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 0 | |
Cost of revenue | Other | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 17,585 | |
Research and development | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 78,915 | |
Research and development | Severance and Related Charges | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 46,994 | |
Research and development | Stock-Based Compensation Expense (Benefit) | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 29,188 | |
Research and development | Lease Exit and Related Charges | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 0 | |
Research and development | Other | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 2,733 | |
Sales and marketing | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 30,791 | |
Sales and marketing | Severance and Related Charges | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 30,565 | |
Sales and marketing | Stock-Based Compensation Expense (Benefit) | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | (504) | |
Sales and marketing | Lease Exit and Related Charges | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 0 | |
Sales and marketing | Other | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 730 | |
General and administrative | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 58,658 | |
General and administrative | Severance and Related Charges | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 17,211 | |
General and administrative | Stock-Based Compensation Expense (Benefit) | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 5,111 | |
General and administrative | Lease Exit and Related Charges | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 31,227 | |
General and administrative | Other | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | $ 5,109 |
Subsequent Events (Details)
Subsequent Events (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Feb. 05, 2024 | Sep. 30, 2023 | Sep. 30, 2022 | |
Subsequent Event [Line Items] | |||
Percentage of employee reduction in reprioritization plan | 3% | 20% | |
Subsequent Event | Global Headcount Reduction | |||
Subsequent Event [Line Items] | |||
Percentage of employee reduction in reprioritization plan | 10% | ||
Subsequent Event | Global Headcount Reduction | Minimum | |||
Subsequent Event [Line Items] | |||
Expected restructuring charges | $ 55 | ||
Subsequent Event | Global Headcount Reduction | Maximum | |||
Subsequent Event [Line Items] | |||
Expected restructuring charges | 75 | ||
Subsequent Event | Global Headcount Reduction | Severance and Related Costs and Other Charges | Minimum | |||
Subsequent Event [Line Items] | |||
Expected restructuring charges | 45 | ||
Subsequent Event | Global Headcount Reduction | Severance and Related Costs and Other Charges | Maximum | |||
Subsequent Event [Line Items] | |||
Expected restructuring charges | $ 55 |